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Synopsis
The liver transplantation procedure was first carried out in 1967 and, since that time, 
survival rates have been steadily improving. The introduction o f the split liver graft 
procedure has now made liver transplantation available to babies under 1 year o f age 
for the first time. This study is the largest in the world into the oral condition of 
paediatric liver graft recipients, it was carried out between 1992 and 1996 and 
contains five separate prospective clinical investigations.
It has already been reported that there is a high prevalence o f intrinsic pigmentation, 
enamel hypoplasia, delayed eruption and cyclosporin-induced gingival overgrowth in 
children with liver grafts. However, the previous studies are few and the number o f 
children in the samples were small. Therefore, the impact o f both the increased 
availability o f liver grafts to babies and the improved survival o f liver graft recipients 
on the fixture paediatric dental need o f these children is still to be fully ascertained.
Paediatric liver graft recipients also have a high nutritional demand both before and 
after liver grafting but, in spite o f this, they have been shown to ‘catch-up’ on their 
peers one year after liver grafting. The effect o f malnutrition on the eruption o f the 
primary dentition and whether the same ‘catch-up’ growth occurs has never been 
investigated.
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The bioavailability o f cyclosporin is already highly variable, especially in liver graft 
recipients, and is likely to be further compromised in babies and infants who receive a 
split liver graft due to poorer absorption. The effect o f age, age at the time o f 
transplantation and duration o f cyclosporin therapy not only on the prevalence and 
severity o f gingival overgrowth but also on the erupting primary dentition also merits 
investigation.
Organ transplant recipients also have a higher risk o f cytomegalovirus infection than 
the general population. It has recently been suggested that there is a link between 
cytomegalovirus infection and cyclosporin-induced gingival overgrowth. However, 
this has never been the subject o f a clinical investigation.
In the first study, fifty-five paediatric liver graft recipients, who represented a cross- 
section o f the children who attended the Liver unit at Birmingham Children’s Hospital, 
were examined. Thirty-seven o f the children were below 5 years o f age. Forty-seven 
percent o f the study group had intrinsic pigmentation but only 11% were found to have 
enamel hypoplasia. The prevalence o f delayed eruption was found to be in excess o f 
40%. Fifty-five percent o f the children had gingival overgrowth. There was a 
significant inverse relationship between the duration o f cyclosporin therapy and the 
trough cyclosporin concentration but analysis o f variance failed to show any 
association between the trough cyclosporin concentration and the severity o f the 
gingival overgrowth.
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In the second study, thirty-seven children with liver grafts who had intrinsic 
pigmentation o f the dental hard tissues were examined and the severity o f the intrinsic 
green pigmentation measured using a specially developed colour scale. The primary 
molar teeth were the most severely discoloured but the results o f this investigation also 
suggest that the permanent incisors and first permanent molars are also likely to be 
similarly, if less severely, affected. The clinical evidence suggested that the deposition 
o f the green pigment was incremental in nature and occurred in the immediate post­
natal period. The study also found that the severity o f the pigmentation did not to 
improve with time.
The third study was a controlled study that compared the effect o f malnutrition, the 
underlying liver disease, and cyclosporin medication in the aetiology o f delayed 
eruption o f the primary dentition. This study confirmed that the prevalence o f delayed 
eruption o f the primary dentition in children with liver grafts was 43%, and 48% in 
those who also had malnutrition. Children with liver grafts had significantly fewer teeth 
than their age-matched controls with liver disease. There was a highly significant 
association between the trough cyclosporin concentration and the number o f teeth in 
liver graft recipients who did not have malnutrition. The results showed that 
malnutrition alone was not a significant aetiological factor. This findings suggest that 
cyclosporin caused delayed emergence o f the primary dentition when there had 
previously been delayed eruption due to severe liver disease.
In the fourth study, ninety-seven paediatric liver graft recipients were examined and the 
study population was divided into groups according to age, then by age at
transplantation and by duration of cyclosporin therapy. The results showed that the 
prevalence o f cyclosporin-induced gingival overgrowth varied with the age o f the 
study sample. It was found that there was lower prevalence o f cyclosporin-induced 
gingival overgrowth in babies and infants, 33% and 55% respectively, compared to 
100% in adolescents.
Although the prevalence o f gingival overgrowth was found to increase with duration 
o f cyclosporin therapy, no significant association was found between the duration of 
cyclosporin therapy and either the presence or the severity o f gingival overgrowth in 
any o f  the age-banded groups.
There was a significant inverse correlation between the trough cyclosporin 
concentration and the duration of cyclosporin therapy in all o f the age groups which 
confirms the finding in the cross-sectional study. This is probably related to the 
difficulty in maintaining optimal therapeutic levels o f the drug in the growing child.
Recipients of liver transplants are becoming ever younger and more numerous. This 
investigation shows that paediatric liver graft recipients will require dental care to 
restore aesthetics, and manage delayed eruption o f the primary teeth and gingival 
overgrowth.
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Chapter One
Introduction
21
Since 1967 more than a thousand liver transplantations have been carried out in North 
America and Europe. This increase in numbers is due to earlier diagnosis and referral, 
improved patient selection and operative techniques, and to the successful 
development o f immunosuppressive agents such as Cyclosporin A and FK506 
(Tacrolimus) which was first clinically introduced in 1989 (Caine et al 1980: Starzl et 
al 1981a, 1989b: Hadley et al 1995). One and two year actuarial survival post OLT in 
world centres is now in excess o f 85% and survival rates in paediatric liver 
transplantation approach 80% at one year and 70% at five years (Whittington & 
Ballisteri 1991).
Orthotopic liver transplantation (OLT) is a technique in which the recipient's liver is 
removed and a donor's liver is implanted in the original site. Liver grafts are matched 
by ABO blood group, size and, when possible, by cytomegalovirus status.
To overcome the shortage o f paediatric donors reduction hepatectomies have recently 
been developed. This is a procedure in which part o f an adult liver is cut down to  fit a 
child. Reduction hepatectomies now make up 46-50% o f the total grafts in children 
and have enabled babies under lyear o f age and 10kg in weight to  be offered liver 
transplantation for the first time (Beath et al 1993). The physiology and anatomy o f 
babies under 1 year produces unique medical complications such as respiratory and 
ventilatory problems, and infection but in spite o f this, 1 year survival rates have been 
reported in the region o f 65% (Sokal eta l 1990).
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Some children with liver disease and liver transplantation also suffer from malnutrition. 
It has been shown that chronically malnourished liver transplant recipients have a 
higher prevalence o f infection, surgical complications, and lower survival rates 
(Moukazel et al 1990).
1.1. Indications for Liver Transplantation
The diseases for which liver transplantation has been performed can be divided into the 
following groups: metabolic diseases, acute and chronic hepatitis, intrahepatic 
cholestasis, obstructive biliary tract disease, tumours, and other miscellaneous 
conditions such as cystic fibrosis. The critical factors that indicate a need for 
transplantation can be classified as; liver disease expected to progress to hepatic 
failure, liver-based metabolic disease, and primary hepatic malignancy. Transplantation 
is not usually considered if there is an alternative therapy or if the outcome will be 
poor (Whitington & Balisteri 1991) but the only absolute contraindications to liver 
transplantation are severe cardiopulmonary disease and irreversible organic brain 
disease (Kelly 1991).
Extrahepatic biliary atresia (EHBA) is the most common disease leading to liver 
transplantation. EHBA affects 0.8-1.0 per 10000 live births. It is the most important 
cause o f death from hepatic failure in children in North America, Europe, Australia and 
Japan.
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EHBA is a disorder of foetal and early postnatal life in which an inflammatory 
sclerosing process produces progressive obliteration o f the extrahepatic biliary tree. 
The majority o f infants with EBHA have an atretic or small gall bladder and complete 
obliteration o f the bile ducts. For these children, hepatic portoenterostomy: the Kasai 
procedure is the treatment o f choice but if it fails these children then proceed to liver 
transplantation, (Johnston 1991).
1.2 Morbidity and mortality of liver transplantation
There is a relatively low prevalence o f chronic rejection in liver allografts compared to 
other transplant procedures. This could either be due to the lower immunogenicity o f 
the liver or to its dual blood supply. When chronic rejection occurs in liver transplant 
recipients it is characterised by progressive loss o f bile ducts, increasing cholestasis and 
obliterative vasculopathy (Lowes et al 1993). However, it is infection that is the major 
cause o f morbidity and mortality in liver transplant recipients. Risk factors for infection 
include: preoperative morbidity, prolonged antibiotic use and operating time, the 
number o f operations, and the magnitude o f immunosuppressive therapy (Dummer et 
al 1983 : Stratta et al 1992). In the immediate post-operative stage bacterial infections 
such as Streptococcus faecalis, Streptococcus viridans, Pseudomonas and 
Staphylococcus aureus are likely. Systemic fungal infections are also common but can 
be prevented using oral anti-fungal drugs and cotrimoxazole is prescribed to prevent 
Pneumocystis carinii (Dummer et al 1983 : Kusne et al 1988 : Kelly 1991a : Kelly 
1991b : Davison 1993).
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1.3 The Liver Unit in Birmingham Children’s Hospital
In 1989 the Liver Unit at Birmingham Children’s Hospital began to provide a national 
service for the management o f liver disease in children. It has a multidisciplinary team 
providing expert care for children o f all ages ranging from small babies to the 16 year 
old child. This includes the management of a range o f diseases from inherited liver 
disease to  acute liver failure and liver transplantation. Approximately 30 liver 
transplants in children are performed each year. The one year survival following liver 
transplantation is greater than 90% and the five year survival is 75%. The unit has also 
developed a combined small bowel and liver transplant programme for children in 
Britain so that they do not have to go abroad for this procedure.
The pre-transplant assessment for children who have been referred to Birmingham for 
liver transplantation includes: anthropometry; blood tests; viral serological screening 
(CMV, Epstein-Barr, varicella, measles, hepatitis A, B & C, HIV); urinalysis; chest 
and bone-age X-rays; abdominal ultrasound and cardiology evaluation. In addition, 
since 1991, the children undergo a dental examination by a paediatric dentist (MTH). 
Following transplantation the following oral medications are prescribed:
•Acyclovir: under 5 years 200mg/dose qds; over 5years 400mg/dose qds 
•Azathioprine 2mg/kg/dose daily
•Cyclosporin 1 mg/kg dose, increasing to 1.5 mg/kg if renal function is good 
•Ranitidine 3 mg/kg tds if under 10 years, 150mgs bd if over 10 years 
•Prednisolone 1 mg/kg dose bd to a maximum dose o f 30 mg daily. Stopped at 3 
months
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1.4 The anticipated dental needs of paediatric liver graft recipients
Children with liver disease require careful oral management due to  their inadequate 
drug and protein metabolism and tendency towards prolonged bleeding. Intrinsic 
discoloration in children with biliary atresia has also been reported. It has been 
suggested that general malnutrition may have an effect on dental development, but 
there is no information in relation to liver disease.
It is clear that as liver transplantation becomes not only increasingly common but is 
also made available for babies and infants, the dental management will be more 
complex. So far published studies have not included preschool children and sample 
sizes have been small. Oral manifestations such as delayed eruption, intrinsic staining, 
and enamel hypoplasia have been subject to anecdotal reports but have not been fully 
investigated.
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Chapter Two
Literature Review
The effect of paediatric liver disease and transplantation on the oral tissues
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The number o f publications pertaining to the dental aspects and dental needs o f 
children with liver disease or liver transplantation are relatively few in number. 
Moreover, they are mainly confined to individual case reports or to studies with 
relatively small numbers and disparate variables. Guidelines on the dental management 
o f patients with liver disease and transplant recipients have also been published but 
have not been based upon clinical investigations (Svirsky 1989: Ziccardi et al 1991 : 
Glassman eta l 1993).
Hyperbilimbinaemia and malabsorption o f the fat soluble vitamins A and D cause 
defects in the formation o f enamel and dentine such as hypoplasia and intrinsic staining. 
It has been reported that children with liver disease and liver transplantation have 
enamel hypoplasia, delayed eruption, and intrinsic green staining o f both the primary 
teeth and soft tissues, cyclosporin-induced gingival overgrowth, a susceptibility to 
dental caries and enlarged pulp chambers. However, sample sizes in these studies 
have been small, ranging from one to nine (Shapiro et al 1975 : Seow et al 1991: 
Funakoshi et al 1992 : Zaia et al 1993 ) and the age range, underlying medical 
condition and other contributory factors were not investigated. The published dental 
literature in respect o f paediatric liver transplantation is summarised in Table 1 
overleaf.
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To date, no large clinical study has been carried out in children with liver grafts to 
elucidate the oral complications o f liver transplantation.
In the following sections the literature pertaining to intrinsic discolouration, enamel 
hypoplasia, delayed eruption o f the primary dentition and cyclosporin-induced gingival 
overgrowth will be presented.
2.1 Intrinsic dental pigmentation
Intrinsically pigmented green teeth and pigmented alveolar bone and oral mucosa, 
have been widely reported in children with liver disease (Marsland & Gerrard 1953 : 
Shapiro et al 1975: Herbert & Delcambre 1987 Van Cleynen & Demars-Fremault 
1990 : Seow et al 1991: Majewski et al 1993 : Zaia et al 1993). The pigment is
thought to be biliverdin but it is not clear if both the enamel and dentine are affected, 
or if the pigmentation occurs pre- or post natally or is incremental in nature. 
Nevertheless, intrinsic green pigmentation appears to be common in paediatric liver 
graft recipients.
2.1.1 Intrinsic pigmentation in children with liver disease
In 1991 , Seow et al reported intrinsic green pigmentation in the primary dentition o f 
infants who had either end-stage liver disease or liver grafts. Although the crowns o f 
the primary teeth were too carious to accurately date the onset, it was stated that the 
pigmentation ceased when the subjects received liver grafts. Funakoshi et al (1992) 
also reported intrinsic green stain in all five o f their subjects, four o f whom were 
children in the primary dentition, who had received liver grafts.
Intrinsic green pigmentation has also been reported in the permanent dentition in a 
seven year old child with a liver graft who had previously suffered from biliary atresia. 
The maxillary permanent central incisors were reported to have normal white enamel 
in the cervical third, but the incisal regions were ‘very green and slightly hypoplastic’ 
(Zaia etal 1993).
Shapiro et al (1975) described two cases o f children with biliary atresia and severely 
pigmented primary teeth. They reported that all o f the teeth, including the roots were 
stained dark green, as were the exposed alveolar bone and buccal plate.
Funakoshi et al ( 1992) also carried out a radiographic and histologic examination but 
they found no evidence o f abnormality. However, Majewski et al (1993) examined 
ground sectioned primary molar and incisor teeth from a 3 year old child with biliary 
atresia and reported that there was prominent interglobular dentine present and focal 
cemental dysplasia.
2.1.2 Historical reports of intrinsic green stained teeth
Reports o f intrinsic green pigmented teeth in the primary dentition are associated with 
hyperbilirubinaemia caused by rhesus incompatibility (Miller 1951: Farquahar 1951: 
Tank 1951: Barta et al 1989). In 1951, Miller reported finding green pigmented teeth 
due to rhesus factor in a child. Pigment was found in those areas o f the tooth formed at 
birth but not in tooth tissue formed thereafter. He concluded that the pigment was laid 
down in those areas o f dentine and enamel which were undergoing calcification during 
the period that the subject was jaundiced.
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2.1.3 Hvperbilirubinaemia and its affect on the enamel organ
Hyperbilirubinaemia causes the deposition of pigment in all parts o f the body. This 
pigment is the result o f the catabolism o f haem-containing proteins such as 
haemoglobin and myoglobin into bilirubin, carbon monoxide and iron. It is thought 
that this pigment is deposited in the enamel organ as biliverdin, which is the oxidation 
product o f the bilirubin molecule. It has also been reported that concentrations o f 
bilirubin have to be in excess o f 30mg/100ml for the green pigmentation o f the dental 
tissues to occur (Zaia et al 1993).
2.1.4 Tooth colour and discoloration
The colour o f healthy teeth is affected by the colour, translucency and the thickness o f 
the enamel together with the colour o f the underlying dentine. Discoloration can arise 
from both extrinsic and intrinsic factors. The former includes chromogenic bacteria, 
food pigment, dye and tobacco. The latter includes dentinogenesis imperfecta, 
amelogenesis imperfecta, fluorosis, tetracycline, lepromatous leprosy, and haemolytic 
diseases o f the newborn such as erythroblastosis foetalis, congenital erythropoietic 
porphyria and liver diseases (Dayan 1983).
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2.1.5 Chronology o f formation o f the dental tissues
Hard tissue formation in the crowns of primary incisor teeth starts between the 13 th to 
the 16th week o f intrauterine life and continues until enamel calcification is completed 
three months after birth (Lunt & Law 1974). If  the deposition o f the green pigment is 
incremental in nature, there is a potential to date the onset o f the hyperbilirubinaemia 
using the pattern o f the pigmentation in these primary teeth. The foetal liver is not 
known to have a role before birth but if the intrinsic green stain is indeed biliverdin, 
and is deposited incrementally in tooth tissue formed prenatally, this could not only 
provide a clue about the true function of the foetal liver but also unlock the possibility 
o f earlier medical detection and treatment o f paediatric liver disease.
The Chronology o f the Formation o f the Dentition is shown in Table 2 overleaf.
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2.1.6 The incremental nature o f intrinsic green pigmentation
It is generally believed that the green pigment is laid down in tissues that are 
undergoing calcification rather than by diffusion through the dentine following hard 
tissue formation (Brearley 1968: Zaia et al 1993). The cessation o f deposition o f the 
green pigment following liver grafting also lends further weight to this hypothesis 
(VanCleynen & Demars-Fremault 1990: Seow et al 1991: Funakoshi et al 1992).
Chronological deposition has also been reported in relation to green pigmentation in a 
premature child who had suffered from hyperbilirubinaemia. All o f the clinical crowns 
o f the maxillary incisors were green in colour but the mandibular central incisors were 
only green in the incisal one-third. This suggested that the intrinsic pigmentation 
occurred in the immediate post natal period (Herbert & Delcambre, 1987).
2.1.7 Acquired pigmentation o f the dental hard tissues occurring in utero
Van Cleynen and Demars-Fremault (1990) reported that incremental intrinsic green 
pigmentation in the primary dentition o f children with biliary atresia appeared to have 
started during hard tissue formation in utero. This report not only suggests an 
incremental distribution o f the pigment but also that the intrinsic green stain might have 
been incorporated into the tooth substance before birth.
Rosenthal et al (1986) also reported two cases where the deposition o f  intrinsic stain 
may have occurred in utero. One o f the subjects was a 2kg infant boy of 32 weeks 
gestation who had green intrinsic staining o f the incisal and middle thirds o f the 
maxillary and mandibular central incisors. The second subject was a 26 month old boy 
with biliary atresia who had intrinsic green pigmentation o f all o f his primary teeth.
There is already evidence, based on reports o f tetracycline pigmentation o f  the 
dentition, that substances can cross the placental barrier and affect the primary teeth 
o f the neonate, (Genot et al 1970 : Anthony 1970 : Dayan 1983 ). However, Marsland 
and Gerrard (1953), who previously examined 170 children with neonatal jaundice in 
Birmingham, reported that dentine laid down pre-natally was not affected.
2.1.8 Distribution o f the intrinsic green pigmentation
It is not clear if the intrinsic green pigmentation is present in both the dentine and 
enamel. Marsland and Gerrard (1953) reported that they found green pigment to be 
present only in dentine. Green pigmentation which was confined to the dentine was 
also reported by Tank (1951) who further concluded that unstained enamel merely 
reflected the underlying pigmented dentine. However, Funakoshi et al (1992) stated 
that the enamel was also stained but to a lesser extent than the dentine.
It has been suggested that the key to the difference between the deposition in enamel 
compared to dentine lay in the different patterns o f development o f these two hard 
tissues. Marsland and Gerrard (1953) believed that the green stain, which was
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thought to be contained in the organic matter, was removed from the enamel during 
the phase of enamel maturation. Interestingly, they also reported that they found no 
correlation between the colour o f the teeth and either the duration or the severity of 
jaundice.
2.1.9 Variation in the intrinsic pigmentation with time
The nature and intensity o f the intrinsic pigmentation has been reported as being 
variable with time. Marsland and Gerrard (1953) reported that the green pigmentation 
appeared to fade over the follow-up period and suggested that this was due to changes 
in the translucency o f the enamel o f the primary dentition with age. The pigmentation 
has also been reported to undergo a colour change from an initial yellow, changing to 
green, before fading completely (Thursfield 1912: Langmead 1912: Barta et al 1989).
It has also been reported that the primary molar teeth are more deeply stained than the 
incisors (Marsland & Gerrard 1953) and that the pigmentation becomes darker 
towards the pulp (Rosenthal et al 1986). This latter finding might simply be 
attributable to the increased area o f dentine in primary molars. However, the primary 
molar teeth are predominantly formed post natally whilst the crowns o f the primary 
incisors predominately form in utero (Lunt & Law 1974). Therefore, if the 
hyperbilirubinaemia occurs only after birth, it is the primary molar teeth that are 
calcifying at the time. Thus if the pigmentation does indeed occur in an incremental 
fashion and affect only those teeth that are calcifying at the time, these primary molar 
teeth are likely to be more stained than the primary incisors.
The colour change and loss of intensity is more difficult to explain. It might be 
attributable to the authors (Marsland & Gerrard 1953: Barta et al 1989) relying on the 
hear-say o f the parents reports o f the affected children rather than a clinical evaluation. 
Nevertheless, Thursfield (1912) and Langmead (1912) carried out sequential 
examinations and both did report that the primary teeth were initially a ‘vivid’ yellow 
in colour which later turned to green.
2.1.10 Summary
The most extensive studies into intrinsic green staining in the primary dentition were 
published in the 1950’s (Tank 1951: Farquhar 1951: Marsland & Gerrard 1953). 
Neonatal hepatitis due to Rhesus incompatibility was eradicated over thirty years ago 
and so investigations into the nature and onset o f intrinsic green staining in infants 
were never fully pursued. Today, children with liver disease have a much greater life 
expectancy, particularly now that liver transplantation is increasingly available. Since 
caries-free, green stained primary teeth could be used to elucidate the role o f  the foetal 
liver the nature, the chronology o f the pigmentation requires further examination.
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2.2 Enamel Hypoplasia in children with liver disease and liver grafts
The mineralised enamel contains a history o f the child’s early life. Enamel does not 
remodel and so disturbances during development remain in the tooth as a permanent 
record (Feame et al 1994). Enamel hypoplasia o f the primary dentition is a valuable 
clue to the child’s well-being before and after birth. The primary central incisors start 
to mineralise during the fourteenth gestational week and the crowns o f the second 
primary molars are completed by 11 months o f age (Lunt & Law 1974).
2.2.1 Definition
Enamel hypoplasia is defined as a quantitative defect o f enamel, visually and 
morphologically identified as involving the surface o f the enamel and associated with a 
reduced thickness. The defective enamel may occur as shallow or deep pits either 
arranged horizontally in a linear fashion or generally distributed around all or part o f 
the enamel surface. The defective enamel may also occur as small or large, wide or 
narrow grooves (Ainamo & Cutress 1982).
2.2.2 Aetiology o f enamel hypoplasia
The aetiology o f developmental enamel defects can be hereditary or acquired and can 
be associated with numerous systemic disorders including, Trisomy 21, epidermolysis 
bullosa, pseudohypoparathyroidism, oculodentodigital dysplasia and 
mucopolysaccharidoses. Enamel defects are also strongly associated with inborn errors
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of metabolism such as phenylketonuria, erythropoietic porphyria, and primary oxaluria. 
Enamel hypoplasia is also related to neonatal disturbance such as premature birth, 
haemolytic anaemia and viral exanthematous diseases o f childhood (Pindborg 1982).
Enamel hypoplasia is probably most extensively reported in relation to fluorosis. Small 
and Murray (1978) reported that the prevalence o f at least one tooth with an enamel 
opacity in children was 14.6% to 83.5% in low fluoride areas 8% to 36.4% in 
optimally fluoridated areas.
i
| Enamel hypoplasia in the primary dentition has been attributed to various factors such
I as fever, and local infection (Pindborg 1982), prolonged hypocalcaemia (Ranggard et
\
al 1995), and trauma to the mineralising primary teeth caused by pressure o f thef
| laryngoscope on the alveolar ridge during intubation has also been implicated (Noren
et al 1993). Enamel hypoplasia of the primary canines has also been found amongst 
| children with nutritional deficiency (Skinner 1994).
t
f
2.2.3 Incidence o f enamel hypoplasia
The presence o f enamel defects in permanent teeth has been reported to be between
30% (Suckling et al 1976) and 49% (Dummer et al 1986) in Caucasians.
Wamakulasuriya (1989) reported a prevalence o f 20% in a study o f Sri Lankan 
children but attributed this low finding compared with other studies to poor lighting. 
Goodman et al (1987) reported a prevalence o f 47% in Mexican children but found 
only 6% o f primary teeth to be affected. However, some o f these studies have counted
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tetracycline stained teeth together with those with enamel defects and no record was 
made as to the past medical history of the study sample (Suckling et al 1976).
2.2.4 Enamel hypoplasia and liver disease
Hyperbilirubinaemia and malabsorption o f the fat soluble vitamins A and D can result 
in defects in the formation o f enamel and dentine (Shapiro et al 1975). Therefore, 
children with liver disease are more likely to  have enamel hypoplasia in the primary and 
permanent dentitions. Seow et al (1991) found enamel hypoplasia in all nine o f the 
children in their study with liver disease. They reported that these enamel defects 
ranged from minor breaks in the enamel to large areas o f missing enamel that appeared 
to be located in those areas o f the primary teeth that were formed postnatally.
2.2.5 Summary
It is likely that paediatric liver transplant recipients have been malnourished and must 
have undergone numerous investigations including endoscopy. The prevalence o f 
enamel hypoplasia has not yet been investigated in this population.
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2.3 Delayed eruption in paediatric liver transplantation
2.3.1 Prevalence and aetiology
Seow et al (1991) reported delayed eruption of the primary dentition in 3 o f the 9 
patients in their study. Proffit (1993) diagnosed delayed eruption only when a tooth 
had failed to erupt six months after the expected time. Under these criteria only one o f 
the patients in the study o f Seow et al (1991) would be defined as having delayed 
eruption. Moreover, three o f the patients in the study had body weights below the third 
percentile and all but one had heights on or below the third percentile but the effect o f 
malnutrition was not taken into account.
2.3.2 Mechanisms o f primary tooth emergence
Tooth emergence is the descriptive term applied to a tooth’s entry into the oral cavity. 
The teeth develop either within a bony crypt or within a bony trough and, as such, an 
intimate relationship exists between tooth eruption and bone growth. Following 
calcification o f the crown, bone resorption occurs in two regions; firstly in the base o f 
the crypt and later around the gubemacular canal, expanding the crypt in the long axis 
o f the tooth. The tooth itself appears to play no active role in the eruption process but 
it has been shown that removal o f either the coronal or apical part o f the dental follicle 
stops the eruptive process.
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I
The density o f bone and the rate o f bone resorption directly influence the rate of 
eruption. Eruption provides the stimulus for growth o f the alveolar process. As such 
the process o f alveolar bone growth and tooth eruption are co-ordinated and the two 
processes are indistinguishable. Calcification o f the crown o f the tooth is a critical step 
in the eruptive process since it provides a rigid mass against which the forces within
!(I
j the follicle can act. Blood pressure in the periodontal ligament, osmotic tissue fluid
I|
| pressure and repetitive impulses have all been proposed as the likely factors to provide
[ the eruptive force. However, ultimately, tooth eruption depends upon the imbalance of
!
| forces acting upon the tooth and the forces resisting its movement (Kardos 1996).
2.3.3 Primary tooth eruption variation between ethnic groups
Primary tooth eruption dates have already been extensively investigated. Previous 
studies have shown that although there is considerable individual variation between
|
| individuals, there is generally very little variation in primary tooth eruption times
between different populations (Roche et al 1964: Lavelle 1979: Magnusson 1982: 
Ramirez et al 1994). Moreover, it has also been shown that gender makes little 
difference in the timing o f the eruption o f the primary dentition (Hitchcock et al 1983: 
Ounsted et al 1987). Therefore, large population studies which measure factors 
related to primary tooth eruption can be cautiously applied to other population groups 
and to boys and girls equally.
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2.3.4 Primary tooth chronology
The Chronology o f the Human Dentition, produced by Logan and Kronfield (1933) 
which was later modified by McCall and Schour was used uncritically as a standard o f 
dental development from the 1940’s until it was modified by Lunt and Law in 1974. 
In the light o f these changes many o f these original papers may need to be revised.
2.3.5 Relationship between somatic growth and eruption o f the primary dentition
Infante and Owen (1973) in a study o f 273 Caucasian children, demonstrated a 
significant association between the total number o f teeth present and the height, weight 
and head circumference in boys and between number o f teeth and height in girls. In 
their study they scored an anterior tooth as emerged if  1mm of the tooth surface was 
exposed and a posterior tooth when all four cusp tips were exposed. However, they 
did not compare the measurements o f height and weight against population norms nor 
against standard growth charts. Nevertheless, they concluded that the timing o f tooth 
emergence was significantly related to general somatic growth and perhaps to 
nutritional status.
2.3.5.1 Prematurity
The timing o f the eruption o f the primary dentition is related to prematurity and birth 
weight. Fadavi et al (1992) examined 31 premature children aged from 15 months to 5 
years of age. The subjects were grouped into three age ranges and the number o f teeth
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that had pierced the oral mucosa were counted. The average number o f erupted teeth 
for the different age groups was then plotted and compared to a norm, composed of 
the subjects reported in the study by Infante and Owen (1973). In addition, the length 
; o f time the subjects had been intubated was compared to the number o f erupted teeth.
The authors reported delayed eruption o f the primary dentition in six out o f eight 
| premature children under two years o f age with low birth weights. Moreover, no
' association was found between either birth weight or intubation period and the number
I o f erupted primary teeth. They concluded that that low birth weight premature children
! had delayed eruption o f the primary dentition in the first 24 months o f life.
i
1 2.3.5.2 'Catch-upgrowth'
\\\
\
The study by Fadavi et al (1992) also showed that, after 24 months, the children
t
I appeared to ‘catch up ’ and achieve norms comparable to healthy children o f the same
; age.
Loevy et al (1989) evaluated dental eruption in premature children with low birth 
weights and the effect o f oral intubation on the palate and compared dental eruption 
patterns to those o f Infante and Owen. In this study, 7 out o f 28 subjects were found 
to have delayed eruption but oral intubation was not related to a high arched palate. 
However, the authors in this study also reported that delays in dental eruption were 
corrected during the second year.
46
2.3.6 The influence o f malnutrition on eruption o f the primary dentition
2.3.6.1 ‘Failure to thrive ’
The term failure to thrive (FTT) is applied to infants and young children who do not 
achieve the normal or expected rate o f growth and is classically subdivided into two 
areas, ‘organic’ and ‘inorganic’. The differential diagnosis o f children who have ‘failure 
to thrive’ is shown in Table 3 below.
Table 3
The Differential Diagnosis Of Children Who Have ‘Failure To Thrive’
•normal child o f short stature •severe developmental delay
•idiosyncratic growth pattern •chronic infection
•breast feeding failure •gastrointestinal disorders
•formula feed errors •metabolic disease
•non-organic failure to thrive •congenital heart disease
from Marcovitch (1994)
However, it is now clear that malnutrition is the primary cause o f failure to grow 
appropriately in all cases of non-organic failure, and in the majority o f organic cases.
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2.3.6.2 Poor nutrition and primary tooth eruption
The eruption o f the primary dentition has been shown to be influenced by poor 
nutrition. In 1992, a study o f 44 children from an inner-city area of South London 
found that there was a significant difference between the number o f erupted teeth of 
infants who were failing to thrive compared to matched controls (Reilly et al 1992). 
The criteria for subject selection in this study were: full-term singleton birth, 
birthweight above the third percentile, and weight for age at or below the third 
percentile aged 12 months and sustained for three months; and an erupted tooth was 
recorded if the cusp tip had penetrated the oral mucosa at the time o f the examination. 
Furthermore, since this study used weight for age parameters to measure FTT it can 
be assumed that these subjects were suffering from acute rather than chronic 
malnutrition.
2.3.6.3 Chronic versus acute malnutrition
Alvarez et al (1990) studied the effects o f malnutrition on eruption o f the primary 
dentition and on dental caries in Peru. In 1990 they examined 1481 children between 1 
year and 13 years o f age and measured the children’s nutritional status using 
anthropometry. In this study, the subjects were further classified as wasted ( weight for 
height <90% o f the 50th percentile ), stunted ( height for age <95% o f the 50th 
percentile), or wasted and stunted. Stunting was used to measure chronic malnutrition, 
whilst wasting was indicative o f current or acute malnutrition. The authors reported 
that wasting and the wasting and stunting were found to have the greatest delay in
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primary tooth eruption. Stunting appeared to have a lesser effect on the eruption. This 
suggested that acute malnutrition (i.e. low weight for height) has a more pronounced 
effect than chronic malnutrition (i.e. low height for age).
In a second study in 1993, Alvarez et al carried out a longitudinal investigation into 
dental caries in the primary teeth o f children who had suffered from infant malnutrition. 
This study not only showed that these children were more susceptible to  dental caries 
but also that by the age o f two years, children who had not been malnourished had 
significantly more teeth than those who had. Moreover, in this study they showed that 
retarded linear growth had the most pronounced effect on primary tooth eruption 
(Alvarez et al 1993). Therefore, it is not clear if it is decreased weight or decreased 
height which is the most significant measure of malnutrition in children in respect o f 
the developing primary dentition.
2.3.7 Malnutrition in children with liver disease
Children with liver disease have a particular predilection for malnutrition. They suffer 
from defective protein and fat metabolism caused by both malabsorption and metabolic 
disturbance (Whitington & Balisteri 1991). It has been shown that severe malnutrition 
(weight and/or height more than 2 standard deviations below the mean) affects 50% of 
children with established cirrhosis (Pierro et al 1989: Beath et al 1993a).
Virtually all candidates for liver transplantation demonstrate at least mild nutritional 
depletion at the time they are assessed for transplantation. The standard treatment o f
nutritionally depleted patients is critically dependent on the administration o f adequate 
calories to ensure optimal use o f protein sources. However, patients with liver disease 
are often protein restricted and so protein-calorie malnutrition, in particular, has been 
well reported in these patients. Malnutrition in children with liver disease is attributed 
to a high catabolic state, anorexia, malabsorption, and decreased protein synthesis and 
is exacerbated by haemorrhage, ascites, encephalopathy, cholangitis and infection 
(Moukarzel eta l 1990).
2.3.7.1 Malnutrition in babies with liver grafts
Babies under one year o f age who receive liver transplants have an even higher energy 
and protein requirement. In this age group, malnutrition secondary to chronic liver 
disease has been reported to be as high as 80% following liver transplantation. 
However, studies have shown that aggressive nutritional support can significantly 
improve the life expectancy (Moukarzel et al 1990 : Beath et al 1993b).
2.3.7.2 ‘Catch-up ’ growth following liver grafting
Children who receive liver grafts have their growth and development carefully 
monitored and receive early and aggressive nutritional support. Beath et al (1993b) in 
a study o f 32 babies, transplanted under 1 year o f age in Birmingham reported a 1 year 
survival o f 88%. Moreover, within 12 months o f liver transplantation they had started 
to ‘catch-up’ on their healthy peers. This finding was attributed to better nutritional
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support and to the discontinuation o f corticosteroids after three months, (Beath et al 
1993b).
2.3.8 The influence o f steroid therapy
It has long been accepted that steroid therapy increases susceptibility to oral infection 
and causes delayed wound healing (Mason 1970). However, it has been shown that 
corticosteroid therapy has no deleterious influence on the clinical parameters o f 
periodontal disease, even with prolonged use (Safkan & Kanuuttila 1984). Indeed, 
there have been reports that topical steroids inhibit gingivitis (Tollefsen et al 1978 : 
Vogel et al 1983). Nevertheless, steroid therapy in children is known not only to 
cause delayed growth and development but has also been shown to cause delayed 
eruption o f the permanent dentition (Luyk et al 1985).
2.3.8.1 Steroids and growth
Blodgett et al (1956) studied the effect o f prolonged cortisone therapy on statural 
growth, skeletal maturation and metabolic status o f children. They showed that the 
drug could, within a few weeks of onset of therapy, slow the rate of statural growth 
and skeletal maturation in children. However, they also reported that children who had 
been given growth suppressing doses o f cortisone underwent a compensatory growth 
spurt when doses were either reduced below growth suppressing levels or were 
eliminated altogether.
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Schunior et al (1990) in a more recent study examined the effects o f irradiation, 
chemotherapy and prednisolone medication on growth and craniofacial proportion, 
using an animal model. The authors reported that although there was significant 
retardation o f growth and craniofacial development attributed to the irradiation, these 
changes were exacerbated by prednisolone medication. Furthermore, there appeared to 
be a difference in the response between males and females. However, the authors also 
concluded that separate studies would have to be carried out to fully differentiate 
between the individual treatment modalities.
2.3.8.2 The effect o f steroid therapy on the dentition
It has been reported that corticosteroid therapy was an aetiological factor in the 
development o f enamel hypoplasia and delayed eruption o f the permanent dentition in 
children with chronic renal failure. However, at the same time, it was also suggested 
that some o f these findings might be equally attributable to the effect o f vitamin D 
deficiency (Bublitz 1981).
There have been no direct reports o f delayed eruption in the primary dentition 
attributable to steroid therapy but it is possible that this is due to  the hitherto small 
number o f infant transplant recipients and the wide variation in children with other 
medical conditions that require steroid therapy.
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2.3.8.3 Steroid therapy in paediatric liver transplant recipients
Steroid therapy in paediatric liver transplant recipients is generally discontinued three 
months after liver transplantation and so the impact o f steroid therapy on delayed 
eruption o f the primary dentition o f paediatric liver transplant recipients is likely to be 
negligible. However, studies that seek to elucidate the causes of delayed eruption in a 
population such as this should take concomitant steroid therapy into account.
2.3.9 The influence o f the overlying soft tissues
The soft tissue which separates the crown o f an unerupted tooth from the oral cavity 
might also influence eruption. The resilience, texture or thickness o f the overlying oral 
mucosa may counteract the forces o f eruption and thereby impede the emergence o f 
the primary teeth in the same way that some permanent teeth require surgical 
exposure.
Di Biase (1971) investigated the nature o f the overlying mucous membrane in 25 
cases of delayed eruption of permanent teeth and compared biopsies from affected 
patients with sections o f normal mucosa overlying second permanent molars that were 
nearing eruption. He reported that the mucosa was ‘fleshy ’ and histological 
examination revealed that the submucosa contained large areas o f immature 
oedematous connective tissue. Histochemical staining disclosed the presence o f 
diffusely distributed mucopolysaccharides but no procollagen, and that it was
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composed o f collagen and immature oedematous tissue which contained a heavy 
deposition o f mucopolysaccharides.
2.3.9.1 Delayed eruption o f the primary dentition
Delayed eruption o f the primary dentition attributable to thickened overlying oral 
mucosa has also been reported. Galili et al (1974) described a case o f a twelve month 
old child with delayed eruption o f the primary dentition who was suffering from I-cell 
Disease, which is a variant o f Hurler’s syndrome. The authors also reported that the 
configuration o f the gingival tissues followed the contour o f the erupted crowns 
suggesting that the alveolar but not gingival emergence had occurred.
2.3.9.2 Drug induced thickening o f the oral mucosa
Delayed eruption attributable to drug induced thickening o f the oral mucosa has also 
been described. Phenytoin has been reported as causing overgrowth o f the oral mucosa 
in an edentulous adult, (Dreyer 1978). Reich et al (1981) reported that a 19 month 
old infant had delayed eruption due to phenytoin therapy which had been prescribed 
soon after birth. However, the child in this report was 'small for her age \
Church and Brandt, (1983) reported the case o f a four-year old child with delayed 
eruption o f the primary dentition which was also attributed to phenytoin therapy. The 
child in this study was suffering from agenesis o f the corpus callosum and had been
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medicated with phenytoin since the first few months o f life. Radiographic examination 
confirmed that the primary dentition was present and that the teeth had erupted 
through the alveolar bone. The primary teeth erupted normally after surgical removal 
o f the overlying oral mucosa.
Appleton and Leach (1991) reported a case of delayed eruption o f all permanent 
teeth in a 13 year old boy diagnosed as suffering from tonic-clonic seizures at the age 
o f seven years and then eventually controlled using phenytoin at the age o f 10 years. 
Radiography confirmed the presence o f the permanent teeth.
Cyclosporin is also known to cause gingival overgrowth but there has never been a 
report o f cyclosporin causing delayed eruption. However, now that cyclosporin is used 
in babies with liver transplants it should not be dismissed as a contributory factor in the 
delayed eruption o f the primary dentition.
2.3.10 Summary
The development and eruption o f the primary dentition is related to somatic growth 
and development but can be influenced by nutritional status, particularly in the first 
year o f life. Medication with cyclosporin, which is known to cause localised 
overgrowth o f the gingivae, and the effect o f steroid therapy have never been 
investigated but may influence the eruption o f the primary dentition in paediatric liver 
transplant recipients.
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Reduction hepatectomy has made liver transplantation available to babies under one 
year o f age. Clearly, the effect o f liver transplantation on the developing dentition 
requires further evaluation. Moreover, the increasing number o f babies and infants with 
liver transplants affords the opportunity to monitor the developing dentition for the 
first time.
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2.4 Cyclosporin
Cyclosporin was first discovered in 1977, and was first used clinically in 1978 in renal 
allograft recipients (Borel et al 1977: Seymour & Jacobs 1992). Cyclosporin is a 
neutral hydrophobic cyclic peptide composed of 11 amino acids. It is produced from 
the fermentation o f two fungi, Trichoderma polyposum and Cylindocarpon lucidum. 
Twenty years after its first introduction, cyclosporin is the first line drug in renal, bone 
marrow, pancreas, and heart and heart-lung transplants and the 96% five year success 
rate o f solid organ and bone marrow grafts can be attributed to its use (Williamson et 
al 1994: Lee & Canafax 1996).
Cyclosporin is now used to treat other systemic diseases which have an immunological 
component. These include: type 1 diabetes mellitus, psoriasis, AIDS, Behcet’s disease, 
multiple sclerosis, myasthenia gravis, erosive lichen planus, allergic encephalomyelitis, 
mycosis fungoides, systemic lupus erythematosus, primary biliary cirrhosis, 
schistosomiasis, chronic active hepatitis and rheumatoid arthritis (Wysocki et al 1983: 
Beveridge 1983 : Seymour & Jacobs 1992 : Williamson et al 1994).
Cyclosporin is a potent immunosuppressive agent that blocks interleukin-2 production 
from CD4+ cells, inhibits T-cell proliferation, binds immunophilin and inhibits 
calcneurin production (Lee & Canafax 1996). As such, cyclosporin directs its action 
towards modulating, at therapeutic doses, the action o f T-lymphocytes on B- 
lymphocytes and by blocking the factors that control cell proliferation (Gelfand et al 
1987: Seymour & Jacobs 1992: Schincaglia et al 1992: Mariani et al 1993).
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Many side-effects o f cyclosporin have been reported. These include: nephrotoxicity, 
hepatotoxicity, neurotoxicity, lymphoma, hypertrichosis, hirsutism, fibrosis o f 
pulmonary, pericardial and renal tissues, convulsions, and hyperbilirubinaemia as well 
as gingival overgrowth, (Caine 1979, 1980: Iwatsuki et al 1983: Rateitschak-Plus et 
al 1983: Wysocki et al 1983: Beaman et al 1985: Von Graffenried & Krupp 1986: 
Modeer et al 1992: Williamson et al 1994).
2.4.1 Pharmacokinetics
Cyclosporin is insoluble, and in the early stages o f its development it was difficult to 
promote its absorption. The Sandimmune formulation o f cyclosporin is an oil in water 
macroemulsion in which the drug is suspended in olive or corn oil and dispensed as a 
soft gelatin capsule or in solution. It is highly lipophilic and is readily distributed 
across most biological membranes. Therefore, cyclosporin is extensively distributed 
throughout the body and the body fluids including saliva (McGaw et al 1987: Modeer 
et al 1992).
Cyclosporin is absorbed from the gastrointestinal tract into enterocytes in the upper 
small intestine. Systemic absorption o f cyclosporin from the gastrointestinal tract 
depends on various factors, such as oil droplet size, bile, lipase, pH, surface area, and 
transit time and is facilitated by either the sodium-requiring transport systems for 
peptides or by uptake by the lymphatic system, (Drewe et al 1992: Lee & Canafax 
1996).
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Once cyclosporin reaches the blood stream it distributes out to the tissues that have a 
high percentage o f fat or into red blood cells. The extent o f the distribution depends 
upon the cyclosporin concentration, hematocrit level, and lipoprotein concentration. 
Thirty-three to forty-seven percent o f cyclosporin is found in plasma, mainly bound to 
lipoprotein. The remainder is bound to erythrocytes, granulocytes and lymphocytes.
Cyclosporin in inactivated by gut and liver enzymes, to produce numerous metabolites. 
Some of the remaining cyclosporin, and most o f the metabolites, are eliminated by 
biliary excretion and so very little is found in the urine. This metabolic destruction 
produces a reported terminal half-life o f 19+9 hours. This half-life is calculated from 
24 hour concentration time profiles that can be influenced by the rates o f resorption, 
distribution, elimination, and redistribution from tissues back into the blood (Lee & 
Canafax 1996).
2.4.1. I Pharmacokinetic variability
Cyclosporin has a wide inter and intra-patient biopharmaceutic and pharmacokinetic 
variability and this has complicated the relationship between dose, blood level, and 
outcome, making it difficult to achieve the desired therapeutic response. The variable 
absorption is partly attributable to patient factors such as time post transplant, type o f 
organ failure or disease, food, race, age, requirement o f other drugs, diarrhoea, 
gastrointestinal motility, hepatic function and bile flow (Tan 1995: Schroeder et al 
1995: Canafax 1996: Lee & Canafax 1996: Schroeder et al 1996). However, the
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factor that is most responsible for blood level fluctuation is the highly variable oral 
bioavailability, which can range from 7 to 92%. The most probable cause for this 
variability in the pharmacokinetics o f cyclosporin is its variable absorption in the small 
intestine (McMaster & Mirza 1994: Superina et al 1994). This hypothesis was 
reinforced by Dunn et al when they reported that intravenous cyclosporin therapy 
produced consistent distribution and elimination in paediatric patients irrespective of 
the transplanted organ, (Dunn et al 1996).
Suboptimal blood levels o f cyclosporin are associated with an increased prevalence of 
acute rejection (Cooney et al 1986). Therefore, for maximal effectiveness, frequent 
blood level monitoring and appropriate dose adjustment is required to maintain trough 
levels in the desired range (Levy 1996).
2.4.2 Cyclosporin in liver transplantation
Liver transplant recipients are not only a very diverse group o f individuals, ranging 
from small babies to adults but they also have a wide range o f liver disorders. 
Therefore, no single cyclosporin therapy schedule fits all clinical situations. Liver 
transplantation presents a unique challenge to the use o f cyclosporin because o f the 
critical illness o f the recipient, difficulties in resorption and metabolism by the grafted 
liver, and the lethal effects o f infection. Moreover, the diversity o f the patients who 
receive liver grafts and their stage o f illness necessitates constant adjustment to the 
immunosuppressive therapy. Indeed, cyclosporin dosage is reduced, or even
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discontinued, in patients who have fulminant hepatitis, infection or hepato-renal 
syndrome (McMaster & Mirza 1994).
Cyclosporin therapy in liver transplant recipients has been shown to have an even 
greater variation in the bioavailability compared to other organ transplantation. This is 
attributable to the fact that cyclosporin is lipid soluble and as such, requires both bile 
and bile salts to be absorbed in the small intestine. In addition, poor hepatic function
| further impairs cyclosporin metabolism, resulting in a shift in the balance between the
I parent drug and its metabolites (McMaster & Mirza 1994).
ii
[
i
iI
[ In the immediate early post-operative period following liver grafting the bioavailability
o f cyclosporin is extremely poor and even more variable. This is because biliary 
diversion in the first few weeks after transplantation and cholestasis are common
j
complications. Moreover, recurrent hepatitis, biliary obstruction, and chronic rejection 
all cause cholestasis following liver transplantation and can even occur a long time 
after transplantation. The absorption of cyclosporin is further adversely affected by 
poor graft function (Cooney et al 1986: Trull et al 1993a, 1994b: Belli et al 1994a: 
Belli et al 1994b: Jamieson et al 1996:). Therefore, parenteral administration is usually 
required. However, intravenous cyclosporin has been shown to cause nephrotoxicity 
(Trull et al 1994).
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2.4.2.1 Cyclosporin therapy regimen in OLT
The majority o f liver transplantation programmes currently use triple therapy schedules 
of cyclosporin, prednisolone and azathioprine. .Cyclosporin therapy is initiated at 2 to 4 
mg/kg intravenously, and then the treatment is converted to oral cyclosporin at 
between 5 to 10 mg/kg o f body weight. However, there is a discrepancy between
centres in regard to the immunosuppressive therapy. Some use cyclosporin and
azathioprine (dual therapy), others include a steroid (triple therapy), whilst some add 
antilymphocyte globulin (quadruple therapy) in the early post transplant period.
| Although the centres with the most intensive drug therapy have reported a reduction in
i
acute rejection the diagnostic criteria have been so varied that comparison between the 
different centres has been impossible. However, intensive drug therapy has been 
associated with a higher prevalence o f infection, particularly with cytomegalovirus
i (McMaster & Mirza 1994).
I
II
The development o f rejection, infection and lymphoproliferative disease in liver graft 
recipients is directly related to the immunosuppressive protocol. In view o f this, the
i
liver transplantation programme in Birmingham uses intravenous cyclosporin combined 
with azathioprine and prednisolone in the early stages following transplant. The patient 
is then switched to oral cyclosporin. Imunosuppression is then maintained using dual 
therapy after cessation o f steroids at 3 months post transplant (McMaster & Mirza 
1994).
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2.4.2.2 Cyclosporin therapy in babies and preschool children with liver grafts
Children, and babies in particular, require large doses o f cyclosporin to achieve 
immunosuppression after liver grafting. This is because children have reduced 
bioavailability but increased plasma clearance (Whitington et al 1990: Dunn et al 
1996).
Children and babies have a more limited absorptive surface area in the small intestine. 
The length o f the bowel increases with somatic growth and is most rapid during 
infancy and in the preschool years, until adolescence when it becomes constant. The 
intestinal surface area increases by a geometric multiple o f the length. Therefore, the 
intestinal surface available for drug absorption in childhood increases rapidly in early 
childhood and, as such, is an important factor in determining the bioavailability of 
cyclosporin in babies and preschool children. A further determinate factor in liver graft 
recipients is the amount o f bowel length that is removed during surgery (Whitington et 
al 1990).
The importance o f the length o f the bowel was subsequently confirmed in a study by 
Dunn et al (1996) who suggested that the other pathological factors that are known to 
influence oral cyclosporin resorption, such as bile flow, may be less important than the 
bowel length in children under two years o f age.
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2.4.3 Neoral
Sandimmune Neoral is a new preparation o f cyclosporin which dispenses the drug as a 
microemulsion. One o f the major benefits o f cyclosporin in a microemulsion form 
(Sandimmune Neoral) is that the absorption is independent o f bile and bile salts. 
Therefore, it is likely that the higher Cmax and area under the curve following oral 
administration o f Neoral will alleviate many o f the difficulties linked to  the variable 
resorption o f the drug. This will be o f particular benefit to liver transplant recipients 
(McMaster & Mirza 1994).
Many studies have already confirmed that the Neoral preparation not only increases the 
bioavailability o f cyclosporin following liver grafting but also produces better long­
term results, even in patients with cholestasis (Trull et al 1993a, 1994b: Belli et al 
1994a: Belli et al 1994b: Levy 1996: Grant et al 1996: Jamieson et al 1996). 
Moreover, the Neoral microemulsion preparation has also been found to have a 
significantly greater bioavailability in paediatric liver transplant recipients (Lin & Lee 
1994: Superina et al 1994: Alberti et al 1995: Dunn et al 1996).
The variation in serum concentration that is commonly found in the Sandimmune 
cyclosporin formulation and the comparison between that and both Neoral and 
intravenous therapy is shown graphically in Figure 1 on the following page.
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Figure 1
Typical Cyclosporin Concentration Time Curve.
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Typical cyclosporin concentration curve following oral Sandimmune (first arrow) and 
oral Neoral (second arrow) administration. C max and AUC are higher and the curve 
follows a more predictable pattern following the Neoral administration. The horizontal 
grey line indicates the steady-state concentration o f cyclosporin on continuous 
intravenous infusion (Superina et al 1994).
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2.4.4 Cvclosporin-induced gingival overgrowth
Gingival overgrowth is the only known oral side-effect o f cyclosporin therapy. It was 
first reported in the early eighties, and was initially compared to the gingival swelling 
caused by phenytoin and the calcium channel blockers (Caine 1980: Rateitschak-Plus 
et al 1983: Wysocki et al 1983: Tyldesley & Rotter 1984: Savage et al 1987: Starzl 
et al 1989a,b: Seymour 1991: Seymour & Jacobs 1992: Dongari et al 1993).
2.4.4.1 The prevalence o f gingival overgrowth in organ transplant recipients
The reported prevalence o f cyclosporin-induced gingival overgrowth in transplant 
recipients is variable at between 8% and 100% (Ross et al 1989: Seymour & Jacobs 
1992: Thomason et al 1993: Dongari et al 1993: Somacarrera et al 1994).
There are some authors who have postulated that this variation in the prevalence of 
gingival overgrowth could be attributed to individual sensitivity either between 
individual subjects or between different fibroblast populations (Hassell & Stanek 1983: 
Wysocki et al 1983 : Daly CG, 1992). However, it could be postulated that this 
variability in cyclosporin-induced gingival overgrowth appears to mirror the inter and 
intra-variability that has already been discussed in respect o f cyclosporin 
bioavailability.
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2.4.4.2 Cyclosporin-induced gingival overgrowth in liver graft recipients
The prevalence o f gingival overgrowth in liver graft recipients is shown in the 
following Table 4 overleaf.
In Table 4, it can be seen that the prevalence o f cyclosporin-induced gingival 
overgrowth in the paediatric liver transplant population has been found to be between 
86% and 100%. This is very much higher than the 53% reported in a recent study o f 
paediatric heart transplant recipients (Lowry et al 1995). However, the studies shown 
in Table 4 had conflicting findings in respect to the effect o f duration o f cyclosporin 
therapy, dose and circulating trough concentration on the presence and severity o f 
gingival overgrowth. Moreover the study populations were relatively small with wide 
age ranges and variable durations o f cyclosporin therapy.
The largest study into gingival overgrowth in paediatric liver graft recipients is by Ross 
et al (1989) who examined the gingival changes in 21 patients following liver 
transplantation. They found that plaque index, gingival index, pocket depth and 
gingival width were all increased in the liver grafted group compared to a control 
group, but reported that there was no significant correlation between the circulating 
cyclosporin and plaque index, gingival index, or pocket depth.
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2.4.5 Pathogenesis o f gingival overgrowth
Cyclosporin-induced gingival overgrowth is firm and pink, with focal lobulations and a 
stippled surface consisting primarily o f a highly vascularised connective tissue with an 
overlying irregular, multi-layered, parakeratinised epithelium o f variable thickness 
(Tyldesley & Rotter 1984: Rateitschak-Plus et al 1983: Wysocki et al 1993).
Wysocki et al (1983) described the excised hyperplastic gingival papilla o f an adult 
renal transplant recipient as smooth, relatively blunt, with some areas exhibiting broad, 
blunt, papillary projections separated by shallow narrow crypts and increased numbers 
o f fibroblasts. Irregularly arranged collagen fibre bundles, in the process o f breakdown, 
and focal accumulations o f inflammatory cells have also been described. Tyldesley and 
Rotter (1984) reported that the predominant feature in cyclosporin-induced gingival 
overgrowth was a proliferation o f collagen fibres in the corium which were lightly 
distributed in a foamy basophilic ground substance.
These histologic findings have been largely confirmed in investigations using serology, 
immunology and electron microscopy. McGaw et al (1988) used serology to 
characterise the influence o f cyclosporin on the individual components o f the gingival 
connective tissue in four renal patients. They reported that cyclosporin-induced 
gingival overgrowth represents a net accumulation o f collagen and other matrix 
materials in addition to a cellular overgrowth. Mariani et al (1993), when looking at 
the ultrastructural features o f the attached gingivae in kidney transplant recipients 
medicated with cyclosporin, reported that there was a particular abundance of
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amorphous substance together with a marked plasma cell infiltration. In a histologic, 
histochemical and immunohistologic examination o f a patient medicated with 
cyclosporin for myasthaenia gravis, Savage et al (1987) also concurred that 
cyclosporin-induced gingival overgrowth is an overgrowth o f fibrous tissue containing 
immuno-competent cells, including plasma cell aggregations, macrophages and T- 
helper cells.
i
Therefore, unlike other examples o f drug-induced gingival overgrowth, cyclosporin
i
| appears to cause a significant increase in the number o f inflammatory cells, collagen 
and matrix, rather than an increase in the fibroblast numbers alone. As such, the 
gingival swelling can be attributed to either an increase in the collagenous elements of 
the connective tissue matrix or to epithelial acanthosis and accumulation o f 
extracellular substance. Consequently, the term gingival overgrowth appears to be 
more appropriate than gingival hyperplasia (Rateitschak-Plus et al 1983: Wysocki et 
al 1983: Tyldesley & Rotter 1984: Lambertenghi et al 1986: Seymour & Jacobs 1992: 
Barber et al 1992: Mariani et al 1993).
|
2.4.5.1 Effect o f cyclosporin on gingival fibroblasts
Cyclosporin modifies the appearance o f gingival fibroblasts (Yamasaki et al 1987) and 
causes a shift in the balance between their generative and degenerative activity 
(McGaw et al 1988). Moreover, it has been shown that there are heterogenous 
fibroblast subpopulations and so cyclosporin, or one o f its metabolites, may act 
selectively on different subpopulations o f fibroblasts. This could also provide an
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explanation to the variation in the prevalence and severity o f gingival overgrowth that 
is found between individuals medicated with cyclosporin (Hassell & Stanek 1983).
2.4.5.2 Effect o f cyclosporin on other components o f the gingivae
Non-cellular components o f the human gingivae, such as the protein fibronectin, 
could be important in the differentiation o f hyperplastic gingival lesions. It has been 
suggested that gingival overgrowth could be caused by cyclosporin creating an 
imbalance between tissue formation and degradation, thereby inducing connective 
tissue accumulation or inhibition o f matrix breakdown (Wysocki et al 1983: 
Yamashaki et al 1987: Barber et al 1992: Schincaglia et al 1992: Seymour & Jacobs 
1992: Romanos et al 1992: Williamson etal 1994).
2.4.5.5 Effect o f cyclosporin on the gingival immune response
Cyclosporin has been shown to modify the immune response within the gingival 
tissues. It has even been suggested that the enormous infiltration o f normal plasma 
cells together with the reversibility o f gingival overgrowth is indicative of a 
hypersensitivity reaction (Lambertenghi et al 1986). Nevertheless, lymphokines, which 
can activate fibroblast activity, can be stimulated or repressed by cyclosporin. 
Cyclosporin has been found to selectively impair Interleukin I release from 
macrophages and also impair Interleukin II from helper T cells (Savage et al 1987). On 
the other hand, the level o f Interleukin-6, which is produced in a variety o f cells in
the presence o f inflammation, such as that found in the gingival tissues when oral 
hygiene is poor, has been shown to be increased by the drug. These studies suggest 
that cyclosporin may exert a direct effect on cytokines to produce gingival overgrowth 
(Williamson et al 1994).
2.4.5.4 Relationship between gingival overgrowth and cyclosporin dose
The relationship between cyclosporin dose and gingival overgrowth has been 
extensively investigated. The varied prevalence and severity o f gingival overgrowth in 
transplant recipients has been attributed to there being a ‘threshold dose’, below which 
the biological effect o f the drug or one of its metabolites on the gingival tissues is 
dispelled (Seymour & Jacobs 1992: Wysocki et al 1983: Daly 1992). Daly (1992) 
concluded that a daily dose o f 700mg was required in order to cause a mild gingival 
enlargement. However, this hypothesis was based upon observations on only one 65 
year old patient with chronic active hepatitis.
Fu et al (1995) evaluated gingival overgrowth with variable dosage o f cyclosporin 
using stone models taken from impressions o f a rat mandible over a two week period. 
They found a significant positive relationship between gingival dimension and both the 
dosage and the duration o f cyclosporin administration. In an in vitro study o f the effect 
o f cyclosporin on human fibroblasts, Coley et al (1986) reported that the effect o f 
cyclosporin on fibroblasts not only varied amongst individuals but was also dose 
dependent.
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However, Daley et al (1986) reported that they found no correlation between the 
mean daily oral dosage and the severity o f gingival overgrowth. The relationship 
between cyclosporin dosage and gingival overgrowth was further disputed in a study 
o f 23 renal transplant recipients in which it was concluded that gingival overgrowth 
was unrelated to cyclosporin dosage (Thomason et al 1993).
2.4.5.5 Gingival overgrowth and trough circulating cyclosporin concentration
Seymour et al (1987) reported a significant correlation between the mean plasma 
concentration scores o f cyclosporin and the increase in gingival overgrowth in 24 adult 
renal transplant patients who were examined at three and six months post transplant. 
Furthermore, in a longitudinal study o f 100 transplant recipients which included heart, 
liver and kidney patients, Somacarrera et al (1994) also suggested that the cyclosporin 
blood concentration was the key factor that influenced gingival overgrowth.
Nevertheless, there have been various studies which failed to show a relationship 
between gingival overgrowth and the trough circulating cyclosporin level. Daly et al
(1986) carried out a prospective longitudinal study o f 100 patients, 18 o f whom were 
transplant recipients and 76 who were diabetics. O f these, 34 had serum trough 
concentrations recorded. They reported that they had not found a correlation between 
the presence o f gingival overgrowth and the serum trough concentration o f cyclosporin 
in the therapeutic range.
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In 1991, Seymour and Smith, in a study o f 27 adult renal transplant patients, also 
concluded that the whole blood concentration o f cyclosporin was not a determinant for 
any increase in gingival overgrowth; a reversal o f their reported findings from a 
previous study in 1987.
Other recent studies have also confirmed that the mean whole blood cyclosporin 
concentration was not related to the occurrence o f gingival overgrowth (Pemu et al 
1992). Indeed, King et al (1993) reported that gingival overgrowth was unrelated to 
cyclosporin dose, blood or saliva level in 66 renal transplant recipients.
Therefore, the relationship between daily dose and the plasma concentration of 
cyclosporin and the development and severity o f gingival overgrowth is still 
controversial. Reasons for the conflicting results may be due to variation in research 
methodology, underlying medical condition, age o f the patient, duration o f therapy, 
concomitant medication and sample size. Moreover, the influence o f the vehicle of 
delivery and the bioavailability on the pharmacokinetics o f cyclosporin has not been 
taken into account in these publications.
2.4.5.6 Age and cyclosporin-induced gingival overgrowth
There have been reports that variation in the prevalence and severity o f cyclosporin- 
induced gingival overgrowth is related to the age o f the patient. Daly et al (1986) 
reported that all forty-seven o f the diabetics in their study, who were under 20 years 
o f age, had gingival overgrowth. This finding was highly significant when the gingival
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overgrowth severity in this group was compared to a similar group o f adults. They 
concluded that adolescents were at greatest risk o f developing cyclosporin-induced 
gingival overgrowth and postulated that this may be attributed to either the added 
effect o f growth hormone on the fibroblastic response or to a greater mitotic and 
secretory capability in young fibroblasts.
2.4.5.7 Effect o f the duration o f cyclosporin therapy on gingival overgrowth
Fu et al (1995) reported that gingival dimensions increased significantly with the 
duration o f cyclosporin administration in rats. Cyclosporin-induced gingival 
overgrowth is seen to occur 2-6 weeks after the commencement o f therapy and the 
changes associated with gingival overgrowth occur most rapidly during the first three 
to six months o f therapy. Cyclosporin-induced gingival overgrowth has also been 
shown to be reversible, with a resolution o f the gingival response once the drug has 
been discontinued. Moreover, the resolution o f gingival overgrowth has also been 
documented following reduction in the daily dosage o f cyclosporin (Daley et al 1992).
2.4.6 The effect o f other oral parameters on cvclosporin-induced gingival 
overgrowth
2.4.6.1 Cyclosporin in saliva
Cyclosporin-induced gingival overgrowth has been related to the concentration o f 
cyclosporin in saliva (McGaw et al 1987: Seymour et al 1987: Seymour & Jacobs 
1992 : King et al 1993). Modeer et al (1992) demonstrated that the gingival tissues are
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exposed to considerable concentrations of cyclosporin when the drug is administered 
in mixture form and therefore postulated that this topical effect o f cyclosporin on the 
gingival tissues could have a role in the pathogenesis o f gingival overgrowth. McGaw 
et al (1987) found a significant correlation between gingival overgrowth scores and 
whole saliva cyclosporin but no correlation was found when parotid or submandibular 
salivary cyclosporin samples were examined separately. They also found that the 
cyclosporin levels in whole saliva in the 30 renal transplant recipients consistently 
exceeded corresponding serum levels.
2.4.6.2 The influence o f plaque on cyclosporin-induced gingival overgrowth
There has been a widely held belief that cyclosporin-induced gingival overgrowth is, 
in part, related to gingival irritants, such as dental plaque, dental calculus, 
imperfections in dental restorations, orthodontic appliances and the effects o f mouth 
breathing (Wysocki et al 1983: Rateitschak-Plus et al 1983: Daley et al 1986: 
Tyldesley & Rotter 1984: McGaw et al 1987: Bartold 1987).
The hyperplastic gingivae and dental plaque share the same environment. This raises 
the possibility that plaque bacteria or one or more o f their components are involved 
directly or indirectly in the hyperplastic response during cyclosporin therapy. Indeed, 
dental plaque together with components o f the immune response may somehow 
modulate the normal mixture o f fibroblast subpopulations by selecting populations 
which have a lower or higher synthetic activity.
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Lipopolysaccharide (LPS) is the main structural component o f the bacterial cell wall in 
gram-negative bacteria. Barber et al (1992) analysed the role o f bacterial LPS in 
cyclosporin-induced gingival overgrowth. They found that although fibroblast 
proliferation was directly stimulated by cyclosporin it was inhibited by LPS. They 
believed that this inhibitory role o f bacterial LPS may provide the explanation to the 
non-cellular nature o f the hyperplastic response. Bartold (1989) found that 
Cyclosporin can also promote fibroblast proliferation in vitro without an alteration in 
synthetic activity and postulated that Cyclosporin may reverse the lipopolysaccharide 
inhibitive effect on fibroblast proliferation.
Daley et al (1986) in a study o f 100 patients who were medicated with cyclosporin 
found that there was a correlation between oral hygiene and the presence o f gingival 
overgrowth but only a weak correlation between the quality o f oral hygiene and the 
severity o f the gingival overgrowth. They concluded that the mild chronic irritation 
caused by dental plaque promotes the hyperplastic effect o f cyclosporin on the gingiva. 
McGaw et al (1987) in a study o f 30 renal transplant recipients found a significant 
correlation between gingival overgrowth and both plaque and gingivitis and proposed 
that dental plaque could act as a reservoir for cyclosporin.
However, not all studies have found that dental plaque is an aetiological factor in 
cyclosporin-induced gingival overgrowth. King et al (1993) in a study o f 66 renal 
transplant recipients, 18 o f whom were medicated with cyclosporin only, found that 
gingival overgrowth was only weakly related to plaque and calculus. Seymour et al
(1987) in a study o f 24 adult renal transplant recipients receiving either azathioprine or
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cyclosporin found no significant difference for plaque scores compared to the gingival 
inflammation present between the two differing drug therapy groups. Tyldesley and 
Rotter (1984) reported that even frequent oral hygiene procedures were insufficient to 
eliminate the gingival changes.
It has been reported that transplant recipients medicated with cyclosporin have a 
significantly increased level o f plaque and this might explain why gingival overgrowth 
is more prominent in areas where dental plaque has accumulated (Bartold 1987). As 
such, it has been suggested that the changes in the gingiva may be attributable to this 
change in plaque index (TD Daly et al 1986: Ross et al 1989: Pemu et al 1992). 
However, the prominence o f plaque as an aetiological factor is controversial and it is 
difficult to compare the differing studies.
2.4.6.3 The synergistic action between cyclosporin and nifedipine
Calcium channel blockers are used in medical practice for various cardiovascular 
disorders such as; angina, cardiac arrythmia and hypertension. Their mode o f action is 
blockage o f the slow calcium channels in the cell membrane. The side effects o f the 
calcium channel blockers include: headache, facial flushes, dizziness, oedema, nausea 
and dyspepsia; and are all attributable to excessive vasodilatation (Seymour 1991).
Nifedipine is a long-acting vasodilator that is widely used for cardiotherapy. It is an 
effective antihypertensive agent. Its main effect is to relax cardiac vascular smooth 
muscle by blocking transmembrane calcium flux through calcium channels The main
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oral side-effect o f nifedipine is gingival overgrowth. The prevalence o f nifedipine- 
induced gingival overgrowth has been reported to be in excess o f 10% (Nishikawa et 
al 1991).
Singer & Zebrowski (1988), in an in vitro study o f the effect o f nifedipine on human 
gingival fibroblasts, demonstrated that the drug caused an increase in cell number, 
enhanced and altered cell attachment and an increased production o f matrix 
constituents. Salo et al (1990) investigated the effect o f nifedipine on collagen and 
protein synthesis and on the cellular proliferation in human gingival fibroblasts in vitro. 
They reported that nifedipine had a specific effect on reducing gingival fibroblast 
cellular total protein and collagen synthesis but had no influence on cell proliferation.
Nifedipine induced gingival overgrowth has been reported as occurring within two 
months o f therapy commencement (Seymour 1991). Nishikawa et al (1991) reported 
two patients with nifedipine induced gingival overgrowth who had been treated with 
the drug for more than three months. One o f the subjects, a 61 year old woman, had 
reported that she had noticed gingival enlargement two months after starting nifedipine 
therapy. Moreover, two months after the nifedipine was discontinued spontaneous 
regression o f the gingival overgrowth was observed.
Therefore, it appears that when nifedipine is discontinued, the gingival overgrowth 
improves moreover, it has even been reported that this improvement can be seen to 
occur in as little as 1 week (Lederman et al 1984).
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Nifedipine is commonly used in transplant recipients to control hypertension and to 
ameliorate cyclosporin nephrotoxicity (Feehally et al 1987). As many as sixty percent 
o f renal transplant patients are initially medicated with a combination o f cyclosporin 
and nifedipine (Thomson et al 1993).
Several authors have reported that the effect o f Cyclosporin and nifedipine on the 
gingival tissues appears to be additive (Thomason et al 1993: King et al 1993). Slavin 
and Taylor (1987) reported that concurrent medication o f nifedipine and cyclosporin 
resulted in an increased rate o f gingival overgrowth when compared to that caused by 
cyclosporin alone.
Thomason et al (1993) reported that the severity o f gingival overgrowth was greater in 
patients medicated with a combination o f cyclosporin and nifedipine. In their study, 
two groups o f renal transplant recipients were examined, 32 were medicated with 
cyclosporin alone and 23 with combined cyclosporin and nifedipine therapy. They 
found that 11 o f the 23 patients on combined therapy had clinically significant gingival 
overgrowth compared to only 12 out o f the 32 patients who had cyclosporin alone. 
However, despite this difference between the two groups the results were not 
statistically significant.
The reported prevalence o f clinically significant gingival overgrowth in subjects who 
were on both drugs ranges from 48% to 51% (McGaw et al 1987: Thomason et al 
1993: King et al 1993). These studies have been carried out on adult renal transplant 
recipients who were found to have clinically significant gingival overgrowth when
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medicated with a combination o f cyclosporin and nifedipine and are significant when 
compared to previous reports o f only a 27% prevalence in a similar population who 
were medicated using Cyclosporin alone.
The reason for the apparent synergistic action o f cyclosporin and nifedipine might lie in 
similarities in their mechanism o f action at the cellular level. Both drugs have been 
shown to inhibit the uptake o f calcium by gingival fibroblasts. In addition, cyclosporin 
and nifedipine cause intracellular calcium depletion which may diminish the synthesis 
and secretion o f collagenase, decreasing the rate o f gingival connective tissue turnover. 
Moreover, both might also be associated with calcium ion exchange, folate uptake, 
increased testosterone metabolism, and alteration o f host immune response. Both 
drugs may also have a similar relationship between dose and severity o f the gingival 
overgrowth which also appears to be affected by plaque, (Dongari et al 1993).
There have been no reports o f the effect of nifedipine on paediatric liver graft 
recipients. This group are generally only medicated with nifedipine in the first few 
months following transplantation, and thereafter only if hypertension persists. It is not 
clear if  the synergistic action o f nifedipine and cyclosporin is dependent on length o f 
exposure time. The effect o f both drugs on the gingivae appears to be reversed when 
the drug is discontinued. Nevertheless, any investigation into the effect o f cyclosporin 
in paediatric liver graft recipients must take the possible effect o f  nifedipine into 
account.
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2.5 Cytomegalovirus
The single most important pathogen in liver transplantation is cytomegalovirus (CMV) 
(Gorensek et al 1990: Stratta et al 1992). CMV infections most commonly occur 5-6 
weeks following liver transplantation. The most frequent manifestation o f CMV 
disease is graft hepatitis but other manifestations include gastrointestinal disease, 
pneumonitis and retinitis. It is likely that CMV promotes other opportunistic 
infections (Chatteijee et al 1978: Paya et al 1993: Hadley et al 1995).
2.5.1 Oral manifestations o f CMV infection
Oral CMV infection is extremely rare but the virus can be cultured in the saliva from 
patients with disseminated CMV infection (Kanas et al 1987: Langford et al 1990). 
The most commonly associated oral manifestation o f CMV infection is salivary gland 
inclusion disease which has been reported in 10 to 30 % o f still births. Furthermore, 
CMV is thought to have a role in other salivary gland diseases such as Sjogren’s 
Syndrome (Cawson & Eveson 1987). There also appears to be an association between 
CMV and oral ulceration in patients with AIDS (Kanas et al 1987: Langford et al 
1990). It has been suggested that the virus may be implicated in the aetiology o f 
recurrent apthous ulceration since CMV is already known to cause ulceration o f  the 
gastro-intestinal tract (Langford et al 1990: Epstein et al 1992). In addition, 
comparisons have been drawn between the epidemiology and immunology o f Acute 
Necrotising Gingivitis (ANG) and CMV infection, suggesting that CMV may be an 
aetiological factor in ANG (Sabiston 1986).
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2.5.2 CMV and gingival overgrowth
In a recent publication, a case was described o f a CMV seronegative male who 
received a seropositive heart transplant and subsequently developed gingival 
overgrowth. Although the authors attributed the gingival overgrowth to CMV the 
patient’s medication included cyclosporin and prednisolone. They reported that 
gingival biopsy confirmed squamous epithelial overgrowth with stromal and chronic 
inflammation which had CMV inclusions in the submucosal vascular endothelial cells 
and stromal fibroblasts. In situ hybridisation for CMV DNA confirmed that the virus 
was present in the stromal fibroblasts and in the vascular endothelial cells. CMV was 
also isolated from the throat, urine, blood and from a gingival biopsy. However, two 
months later when the gingival overgrowth had resolved the CMV culture was 
negative. The authors postulated that in this case gingival overgrowth occurred due to 
the infiltration o f CMV infected cells, inflammatory cell infiltration and oedema, 
(Epstein et al 1992).
However, this patient’s immunosuppression was ‘significantly reduced’ at the same 
time and so the observed resolution o f gingival overgrowth and conversion to CMV 
negative may have been coincidental.
2.5.3 CMV in liver transplantation
The serological CMV status determines the risk o f infection following liver 
transplantation. If both the recipient and donor are seronegative there is little risk o f
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infection provided CMV-negative blood products are used. If  either the donor or the 
host is seropositive the risk o f CMV infection is high (Whitington & Balisteri 1991). 
As a consequence o f CMV transmission from CMV sero-positive donors liver
transplants are matched, where possible, by CMV status (Hersman et al 1982:
Meyers et al 1986: Arnold et al 1991: Sutherland at al, 1992: Paya et al 1993: Hadley 
etal 1995).
I CMV is a very common virus, 45% to 80% of the population developing CMV
■ antibodies at some time in their lives. Prevalence depends on age, sex and socio-
I
| economic background but there is a predilection for the immunosuppressed and for
i
| organ transplant recipients in particular (Naraqi et al 1978: Sabiston 1986: Stratta et al
1992). The reported prevalence o f CMV infection following liver transplantation is as 
high as 40% and following kidney transplantation as high as 73% (Gorensek et al 
1990: Naraqi et al 1978: Chatteijee et al 1978). The most severe CMV infections 
occur in bone marrow transplant recipients (Meyers et al 1986: Stratta et al 1992).
I Congenital CMV infection has also been reported in the offspring o f liver transplant
j
recipients (Laifer et al 1995).
Stratta et al (1992), in a review article o f CMV infection, associated with liver 
transplantation, reported that the prevalence o f CMV infection in liver transplantation 
ranges from 35% to 60% with higher prevalences attributable to seropositive allografts 
and much lower prevalences attributable to reactivation and transfusion o f blood 
products.
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Infection most commonly occurs within the first few months following liver 
transplantation coinciding with the immediate period o f maximal immunosuppression. 
(Naraqi et al 1978: Hersman et al 1982). The most common site o f infection following 
liver transplantation is the transplanted liver graft. CMV hepatitis occurs in 4% of 
recipients of liver transplantation and may be severe enough to warrant 
retransplantation. In a retrospective cohort study, CMV infection occurred in 33% o f 
recipients and CMV disease occurred in 19% (Hadley et al 1995). Over half o f the 
liver transplant recipients who have CMV infection progress to CMV disease (Stratta 
et al 1992). CMV disease and recurrent CMV disease in particular, is usually 
associated with extrahepatic sites such as the gastrointestinal tract and the lungs 
(Naraqi et al 1978: Meyers et al 1986: Stratta et al 1992: Wiens et al 1993: Hadley et 
al 1995). The clinical management o f CMV disease consists o f early detection, 
variable reduction in immunosuppression, optimal nutritional and metabolic support, 
and drug therapy (Stratta eta l 1992: Boudreaux et al 1993: Chen et al 1994. Schmidt 
eta l 1995: Winston eta l 1995).
2.5.4 Diagnosis o f CMV infection
Diagnosis o f CMV infection is made on the basis o f the presence o f any one o f the 
following in the absence o f clinical symptoms:-
•  Isolation or identification o f CMV from any site, including blood, urine, sputum
or stool.
•  Positive seroconversion displayed by either the presence o f CMV-IgM or o f a
four-fold increase in CMV-IgG titres using complement fixation.
•  Objective clinical findings (Stratta et al 1992)
85
The diagnosis o f CMV disease is made when CMV infection is invasive or 
symptomatic in nature. This is then confirmed histologically or by positive CMV 
culture from a deep tissue specimen (Stratta et al 1992: Sido et al 1993). The 
development o f CMV disease is related to viral load and also to the degree o f 
immunosuppression. (Meyers et al 1986: Stratta et al 1992: Wiens et al 1993: Hadley 
eta l 1995:)
Therefore, CMV infection following transplantation is due to either reactivation of 
latent virus, primary infection, or reinfection.
2.5.5 Risk factors for CMV
Risk factors for CMV following organ transplantation have been identified. These 
include type and intensity o f immunosuppression, use o f antilymphocyte globulin, 
cytotoxic drugs, corticosteroids, age, sex, race and underlying disease (Gorensek et al 
1990). CMV and the immune system seem to exert reciprocal effects on each other. 
Indeed, CMV seems to act as an immunosuppressant and as such may interact with 
the allograft to induce dysfunction or provoke rejection (Stratta et al 1992: Briggs 
1972: Naraqui et al 1978). Therefore, not only can CMV status act as an indicator o f 
the net state o f immunosuppression but also the presence o f CMV disease can signify 
over immunosuppression (Stratta et al 1992).
The risk o f CMV disease or infection is higher with primary rather than secondary 
infection (reactivation). Donor availability currently precludes the matching o f
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donor/recipient according to CMV status, thus children who are seronegative at 
transplant are at particular risk o f CMV disease. In the Liver Unit at Birmingham 
Children’s Hospital, 75% of children are seronegative at transplantation. The 
prevalence o f CMV infection following liver transplantation is 38% (Davison et al
1993).
Thus, both cyclosporin and cytomegalovirus appear to influence or be influenced by 
the immune response. The paper by Epstein et al (1992) suggests that CMV 
influences cyclosporin-induced gingival overgrowth. It is an interesting hypothesis that 
should not be disregarded since concomitant CMV infection may be confounding 
studies that seek to determine the mechanism o f cyclosporin induced gingival 
overgrowth.
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2.6 Literature Summary
Liver transplantation is not only increasingly successful but is now available to babies 
under one year o f age. Therefore, the population o f liver graft recipients is going to 
include an ever larger number o f infants and children. As such, liver transplantation 
presents new challenges to both the medical and dental professions. To date there 
have been very few studies into the effect o f liver transplantation on the oral tissues of 
children with liver grafts.
2.6.1 Intrinsic green pigmentation
The majority o f the children who receive liver grafts suffer from extra-hepatic biliary 
atresia but although intrinsic green pigmentation o f the dental tissues in this population 
has already been reported the prevalence in the primary and permanent dentitions is, as 
yet, unknown.
The largest studies into intrinsic green pigmentation were carried out over thirty years 
ago and were mainly focused on subjects with rhesus incompatibility. The intensity o f 
the pigmentation in these subjects has been reported not only to be variable between 
individuals and between teeth but also to improve with time. This information could 
be used to reassure the parents o f children with liver grafts who have intrinsic 
pigmentation but these previous studies based their findings on subjective rather than 
objective measurement.
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Although it has already been suggested that the deposition o f the green pigment 
ceases on receipt o f a liver graft, it is still unclear whether or not the pigmentation 
found in children with EHBA and metabolic liver disease is deposited in utero. The 
chronology o f the development o f the primary dentition could be used to date the 
onset o f the staining and, by so doing, give an indication o f the true physiological and 
pathological status o f the foetal liver.
2.6.2 Enamel hypoplasia
Hyperbilirubinaemia and malabsorption o f vitamins A and D might result in defects of 
the enamel and dentine and, indeed, enamel hypoplasia has been reported in relation to 
liver disease and liver transplantation. However, there are no epidemiological data on 
the prevalence o f enamel hypoplasia in paediatric liver graft recipients.
2.6.3 Delayed eruption o f the primary dentition
Delayed eruption o f the primary dentition has already been reported in paediatric liver 
graft recipients but the study sample was small and if the criteria for the diagnosis of 
delayed eruption had included an elapse o f a six month period beyond the eruption 
dates o f Lunt and Law (1974) only one subject would have been affected.
Delayed eruption o f the primary dentition has been found to be both related to  somatic 
growth and adversely affected by malnutrition. Paediatric liver graft recipients have a 
particularly high nutritional demand but they also receive aggressive nutritional
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support. Moreover, the somatic growth o f children who receive liver grafts has been 
shown to ‘catch-up’ one year after liver transplantation and so one would expect any 
delay in the eruption o f the primary dentition to be quickly reversed.
Paediatric liver graft recipients make up the youngest population in the world to be 
medicated with cyclosporin. Other drugs which cause gingival overgrowth have been 
reported in association with delayed eruption o f both the primary and secondary 
dentitions. However, the likelihood that cyclosporin might also act as an aetiological 
factor in delayed eruption of the primary dentition has never been investigated.
The prevalence and aetiology o f delayed eruption o f the primary dentition in paediatric 
liver graft recipients is still to be investigated. The increasing number o f babies 
receiving liver grafts will facilitate such an investigation for the first time.
2.6.4 Cvclosporin-induced gingival overgrowth
Cyclosporin therapy in liver graft recipients has to be tailored to each individual 
patient. The dose is measured according to age, liver disease, severity o f disease and to 
the presence o f complications such as infection. Cyclosporin is already known to have 
large inter and intra-individual bioavailability but this is even more pronounced in liver 
graft recipients. Moreover, the bioavailability in babies and in pre-school children is 
even more variable due to poorer absorption and the maintenance o f optimal levels 
has to keep pace with growth.
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The prevalence o f cyclosporin-induced gingival overgrowth in paediatric liver graft 
recipients has been found to be high, between 86% and 100%. However, the previous 
studies into gingival overgrowth in this population have not only been few in number 
but they have also had very small samples. Since liver grafts are now available to very 
young children the effect o f other variables on the prevalence and severity o f gingival 
overgrowth such as the age o f the child, the age at transplantation and the duration of 
cyclosporin therapy require investigation for the first time.
2.6.5 Cytomegalovirus
Infection is the major cause o f morbidity and mortality following liver transplantation 
and the single most important pathogen is cytomegalovirus.
It has been shown that CMV and the immune system exert reciprocal effects on each 
other. Cyclosporin has also been shown to modify the immune response within the 
gingival tissues. It has been suggested that cytomegalovirus might have an influence 
on cyclosporin-induced gingival overgrowth.
Since there is already known to be a fine balance between the immune response and 
CMV infection in liver graft recipients, this population appears to offer the best 
opportunity to test this hypothesis.
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3.0
Aims of the investigation
The Null Hypotheses
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3.1 Aims of the investigation
The aims o f this clinical study are:
1. To report on the prevalence o f intrinsic green pigmentation, enamel hypoplasia, 
delayed eruption o f the primary dentition and cyclosporin-induced gingival 
overgrowth in children with liver grafts.
2. To measure the association between the trough cyclosporin concentration and 
concomitant nifedipine therapy on the presence and severity o f gingival overgrowth.
3. To report on the severity, variability and distribution o f intrinsic green pigmentation 
in the primary and permanent dentitions o f paediatric liver transplant recipients.
4. To measure any change in the severity o f the intrinsic pigmentation.
5. To evaluate the role o f the previous liver disease, the presence o f malnutrition, and 
medication with cyclosporin in the aetiology o f delayed eruption o f the primary 
dentition.
6 . To investigate the effect o f age, the age at transplantation and the duration o f 
cyclosporin therapy on the prevalence and severity o f gingival overgrowth.
7. To evaluate the influence o f cytomegalovirus on cyclosporin-induced gingival 
overgrowth.
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3.2 The null hypotheses
The null hypotheses in this study are as follows:
1. Children with liver grafts do not have an increased prevalence o f intrinsic green 
pigmentation, enamel hypoplasia, delayed eruption o f the primary dentition or 
cyclosporin-induced gingival overgrowth.
2. The distribution o f the intrinsic green pigmentation is neither incremental nor 
deposited in utero and there will be no improvement in the severity o f the green 
pigmentation with time.
3. Delayed eruption o f the primary dentition is not related to the previous liver disease, 
malnutrition or cyclosporin therapy.
4. There is no association between the trough cyclosporin concentration and gingival 
overgrowth in paediatric liver graft recipients.
5. Cyclosporin-induced gingival overgrowth is not affected by the age o f  the child, 
their age at transplantation, or by the duration o f cyclosporin therapy.
6 . Cytomegalovirus does not influence the effect o f cyclosporin on the gingival tissues.
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4.0
Clinical Studies into the Oral Condition of Paediatric
Liver Graft Recipients
Material, Method and Results
I
[
i
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4.1 Introduction
This study was approved by the Medical Ethics Committee at Birmingham Childrens’
Hospital.
A total o f five clinical studies were undertaken:
•  a cross-sectional study to investigate the prevalence o f intrinsic green pigmentation, 
enamel hypoplasia, delayed eruption of the primary dentition and cyclosporin- 
induced gingival overgrowth in children with liver grafts.
•  a clinical evaluation o f the severity and chronology o f intrinsic green pigmentation
•  a controlled study to investigate the aetiology of delayed eruption o f the primary 
dentition in liver graft recipients
•  a report on the prevalence and severity o f cyclosporin-induced gingival overgrowth 
when the following variables were rendered constant:
(a) age at examination
(b) age at transplantation
(c) duration o f cyclosporin therapy
•  an investigation to examine the influence o f cytomegalovirus on cyclosporin- 
induced gingival overgrowth
The children in each o f the studies were examined by the author after verbal consent 
had been obtained from their parent. In four o f the studies, the children were 
examined by the author when they attended the Liver Unit for their regular out-patient 
medical review. In the remaining study, the evaluation o f the aetiology o f delayed 
eruption of the primary dentition, examinations were carried out on children who were 
attending both the Liver Unit out-patient clinic and associated gastroenterology and 
dietetic clinics.
All o f the studies were prospective except the final evaluation into the effect o f CMV 
infection on cyclosporin-induced gingival overgrowth. In this study the CMV status 
was matched retrospectively after the dental examination had already been performed. 
In this way the investigator was blind as far as the CMV status until after the dental 
examinations had been performed.
The Liver Unit is a supra-regional centre and so children and their parents travel from 
all over the country to attend the out-patient clinic. Therefore, collection o f the data 
for these studies was dependent upon the liaison between the author and Graham 
Gordon, the co-ordinator o f the Out-patient Liver Unit Clinic. It was he who then 
directed the children and their parents towards the dental clinic, between visits to the 
paediatricians, phlebotomist, dietician, physiotherapist and social worker!
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The Liver Unit has a data base, which became computerised during the course o f this 
study, to which the author was given unlimited access. This data base contains all o f 
the laboratory investigations that are carried out on each liver graft recipient. The 
cyclosporin concentrations are closely monitored and blood samples are generally 
taken during the out-patient visits, the results are later logged onto this data base. This 
allowed the author to retrospectively match the cyclosporin concentrations to the 
dental examinations.
i
|
i
i
I
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4.2
Cross-Sectional Study into the Oral Condition of Paediatric Liver
Graft Recipients
4.2.1 Study sample
Fifty-five children (32 girls and 23 boys) were examined over an 18 month 
period. The mean age was 56 months (range 8 months to 194 months, median 42 
months).
4 .2 .I.I. Diagnosis prior to transplantation
The diagnosis prior to transplantation for children in the study is shown in 
; Table 5 following.
[i
;
Table 5
Diagnosis Prior to Liver Transplantation
Diagnosis prior to liver transplant Number o f Children
Extrahepatic biliary atresia 24
Fulminant hepatitis 12
Alpha 1 antitrypsin deficiency 6
Tyrosinaemia 5
Cryptogenic cirrhosis 3
Hepatoblastoma 2
Allegilles syndrome 1
Primary oxalosis 1
Wilson's disease 1
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4.2.2 Methodology
4.2.2.1 Data collection
Children were examined in the dental unit either in the dental chair or on their mother’s 
knee, where appropriate. A dental light source was used whenever possible but, for a 
minority o f the children, a fibre-optic pen torch was used.
The following information was collected:
Medical and transplant history :
•  age and sex o f patient
•  age at transplant
•  time post transplant
• drug history :in respect o f cyclosporin, nifedipine and steroid therapy.
•  serum cyclosporin concentration: the mean calculated from the blood sample taken 
on the day o f the examination and on the concentrations recorded from the 
previous two out-patient visits.
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The Dental Examination:
• teeth present :all erupted or partially erupted teeth were charted as present. A 
tooth was considered to be delayed when there was a delay o f greater than six 
months outwith the normal eruption dates according to (Lunt and Law 1974) 
which is shown in Table 6
•  hypoplastic defects :using the Thylstrup and Fejerskov Index (1978) which is 
shown in Table 7
•  intrinsic staining : scored as being present or absent.
•  gingival overgrowth: measured using an Index of Severity o f Gingival Overgrowth, 
shown in Table 8 . A score was allocated which related to the degree o f tooth 
coverage caused by gingival overgrowth. All teeth were examined and the final 
score was that which reflected the most severe gingival overgrowth found in each 
subject.
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Table 6
Eruption Times O f The Prim ary And Perm anent Dentitions
Tooth Eruption Date
A
months 
10 (8-12)
MAXILLA B 11 (9-13)
C 19 (16-22)
D 16 (13-19)
E 29 (25-33)
A 8 (6-10)
MANDIBLE B 13 (10-16)
C 20 (17-23)
D 16 (14-18)
E 27 (24-30)
1
Years
7 - 8
2 8 - 9
M AXILLA 3 11-12
4 10-11
5 10-12
6 6 - 7
7 12-13
8 17-21
1 6 - 7
2 7 - 8
3 9 -1 0
MANDIBLE 4 10-12
5 11 -12
6 6 - 7
7 11-13
8 17-21
Lunt & Law 1974
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Table 7
Thylstrup & Fejerskov Index
Score Clinical Description
l narrow white lines
2 pronounced white lines
3 cloudy areas
4 entire surface opaque
5 opacity and pits
6 horizontal bands o f pits
7 outer enamel lost <half surface
8 outer enamel lost >half surface
9 changes in anatomy
Table 8
Index Of Severity Of Gingival Overgrowth
Score Clinical Description
0 No observable overgrowth
l Overgrowth o f gingival tissue extending to 1/3 o f the crown
2 Overgrowth o f gingival tissue extending to middle o f crown
3 Overgrowth o f gingival tissue extending over 2/3 o f the crown
4 Overgrowth o f gingival tissue completely covering the crown
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4.2 .2 .2  S ta tistica l analysis
Data were analysed using the SPSS PC statistics package. The association between the 
level o f gingival overgrowth and the trough cyclosporin concentration was examined 
using Analysis o f Variance (ANOVA). The association between the presence o f 
gingival overgrowth and concurrent nifedipine medication was examined using the Chi- 
square Test. Pearson's Product Moment Correlation Coefficient was used to quantify 
the association between the duration o f cyclosporin therapy and the level o f gingival 
overgrowth. A level o f p< 01 was accepted as statistically significant.
4.2.3 Results
The mean time that the children in the study had been in receipt o f a liver graft was 
lyear 5months (range 1 month to 5 years). Their mean age at transplantation was 3yrs 
4 months (range 6 months to 14 years 6 months). Table 9 gives the composite findings 
related to delayed eruption, enamel hypoplasia, intrinsic staining and gingival 
overgrowth.
Table 9
Dental Findings In Children With Liver Grafts
Stage of Dental Development Number of children
primary dentition 42
permanent dentition 2
mixed dentition 11
Dental Finding Teeth affected Num ber of 
children examined
Num ber of 
affected children
Delayed eruption Primary 42 7
Permanent 13 0
Enamel
hypoplasia
Primary (incisors) 42 3
Permanent
(incisors)
13 3
Intrinsic staining Primary (all teeth) 42 25
Permanent 13 1*
Gingival
overgrowth
55 30
* early mixed dentition
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4.2.3.1 Delaved emption o f the primary dentition
There were 17 children under 36 months o f age. For 7 (41%) o f these infants, eruption 
of various primary teeth was delayed, that is delay of greater than 6 months outwith 
normal eruption dates (Lunt and Law 1974: Proffit 1983). For example, three o f these 
children were 20 months of age and only had some or all o f their primary central 
incisors. There was no delay in eruption found in children above 3 years o f age. All 
seven o f these children had suffered from biliary atresia and six o f them had been 
medically diagnosed as having ‘failed to thrive’.
4.2.3.2_______Enamel hypoplasia
Six o f the fifty-five patients (11%) had evidence o f enamel hypoplasia. Three o f these 
had enamel hypoplasia affecting permanent central incisors, two scored "1" on the 
Thylstrup and Fejerskov Index and one scored "2". The hypoplastic areas 
corresponded to the stage o f development o f these teeth at the time o f transplantation. 
The other three children had hypoplastic defects scoring "1” on the primary central 
incisors. The two children with hypoplasia o f the permanent dentition were both 
transplanted following mineralisation o f the affected permanent teeth and the 
hypoplasia appeared to be attributable to enamel mottling, especially since both o f 
these children had always lived in a fluoridated area. An illustration o f one o f these 
children is shown in Figure 2 overleaf.
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Figure 2
A 7 year old child, 3 years post OL T with enamel hyploplasia o f the permanent 
incisors which scored  ‘2 ’ on the Thylstrup & Fejerskov Index.
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42.3.3 Intrinsic green pigmentation
Twenty-five patients (49%) had intrinsic green pigmentation o f the primary dentition 
but 23 o f these had previously been diagnosed as having biliary atresia. All o f the 
primary teeth in the 25 children were found to be affected but the primary first and 
second molars were more deeply stained than the incisors and canines. One patient had 
intrinsic staining affecting permanent incisors but she had been transplanted at the age 
o f 3. This was relatively late compared to the others with biliary atresia and so she had 
remained jaundiced for much o f her infancy.
! 4.2.3.4_______Gingival overgrowth
i
|
I Thirty ( 55%) o f  the fifty-five children had evidence o f gingival overgrowth. Serum
! cyclosporin levels ranged from 0 to 342 ng/ml with a mean 152 ng/ml. No significant
relationship was found between the circulating cyclosporin level and the presence o f 
gingival overgrowth using analysis of variance (F= 0.69, p =0.78). There was a 
significant inverse correlation using Pearson's Product Moment Correlation Coefficient 
between the duration o f cyclosporin therapy and gingival overgrowth r =-0.33 (p> 01).
Fourteen patients were taking nifedipine in addition to cyclosporin at the time o f the 
dental examination. The mean time they had been taking nifedipine was 4 months 
(range 1 to 12 months). No significant relationship was found between the presence o f 
gingival overgrowth and concomitant nifedipine medication (Chi-square 0.17, 
p=0.77).
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O f the 34 children who had gingival overgrowth, 11 had a severity score o f ‘1’, 17 
scored ‘2’ and 6 scored ‘3’. These findings are shown as frequencies in Figure 3 
overleaf. The mean trough cyclosporin concentration in relation to the severity o f the 
gingival overgrowth in this sample is shown in Figure 4 overleaf.
Illustrations o f two o f the children examined as part o f this study are shown in Figure 5
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Figure 3
Gingival Overgrowth Severity in Paediatric Liver Graft Recipients
n=55
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Figure 4
Trough Cyclosporin Concentration Compared to Severity of Gingival
Overgrowth
ng/ml
400
300
200
100
Index of Severity of Gingival Overgrowth
The black circle represents the mean trough cyclosporin concentration within each 
group o f children who scored ‘0 7  ‘2 ’ and so on using the Index o f Severity o f
Gingival Overgrowth scale. The grey arrows represent the trough cyclosporin 
concentration range within each group.
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Figure 5
Some of  the children examined as part o f  this clinical study. 
(A) 5 year old child, 3 years post OLT
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Figure 5
(B) 4 year old child, 2 years post OLT
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4.2.4 Reproducibility of the gingival overgrowth severity evaluation
4.2.4.1 Method
During the course o f this study the author arranged to re-examine as many children as 
possible within three months o f their first examination. Despite the distance travelled 
and their infrequent attendance at the Liver Unit, reproducibility data from a sample 
o f 13 children were obtained. This represented 24% of the original study sample.
!
i
4.2.4.2 Sample
i
!I
I Table 10 below summarises the demographic information in the study sample.
!
I Table 10
i\
\
Reproducibility Study Sample
sex M:F 9 : 4
mean age 63 months
duration of cyclosporin therapy 23 months
age at OLT 30 months
mean cyclosporin conc. 177 ng/ml
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4.2A .3  Result
Cohen’s Kappa statistic was calculated to measure agreement between the gingival 
overgrowth severity scores that were obtained at the two examinations. The 
reproducibility in the gingival overgrowth severity scores was 0.45, indicative o f 
moderate agreement (Landis and Koch 1977).
4.3
An Investigation into Intrinsic Dental Pigmentation in Children with
Liver Transplants
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4.3.1 Introduction
The aim o f this study was to examine the severity, distribution and chronology o f 
intrinsic green pigmentation both in the primary and permanent dentitions and to 
measure whether the colour of the intrinsic pigmentation reduced with time.
This study was divided into three discrete investigations:
1. A clinical study in which the severity o f the intrinsic pigmentation was measured in 
both liver graft recipients with full primary dentitions and in liver graft recipients 
with permanent incisors and first molar teeth. A colour scale which was specially 
developed for the purpose o f this study was used.
2. A longitudinal investigation evaluated the severity o f the green pigmentation over a 
three year period.
The reproducibility o f the data obtained using the colour scale was also reported.
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4.3.2 Clinical study into the severity of the green pigmentation
4.3.2.1 Methodology
The dental examinations were carried out over a four year period, a total o f 97 
children with liver grafts were examined. Of these, only 37 were found to  have intrinsic 
pigmentation o f the dental hard tissues. These children came from different parts o f the 
country and some attended the Liver Unit out-patient clinic infrequently.
The following study groups o f children were identified:
•  children with a full primary dentition
•  children in the early mixed dentition
Children with intrinsic pigmentation who did not satisfy the criteria for inclusion into 
the primary dentition study group above but who continued to be examined in order to 
obtain further data which could be used both in the evaluation o f the change o f colour 
with time and in the examination o f the reproducibility o f the Intrinsic Green 
Pigmentation Severity Scale.
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The following information was collected for both study groups:
•  diagnosis prior to transplant
• the severity o f the ‘greenness’ was measured on a newly developed colour scale 
which is shown in Figure 6 overleaf. Using this colour scale each individual tooth in 
each subject was given a ‘severity o f greenness’ score ranging from ‘0’ to ‘5’.
The intrinsic green pigmentation severity scores for each primary tooth in each child 
who had a full primary dentition were then summed together to give an overall score.
In the mixed dentition group, the intrinsic green pigmentation severity score for each 
erupted permanent molar and permanent incisor in each child was noted but not 
summed.
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Figure 6
Severity O f Intrinsic Green Pigmentation Colour Scale
* 3 parts vermilion in I part water
• 4 parts sap green in I part water
• I part cadmium yellow I part water
I part water added to the above to give the colour code fo r  score '5'
an additional 1 part w etter was added to produce score 4'
then an additional I part o f water was added to produce score '3 ' and so on. 
( Daler-Rowney w atercolour codes: *588; **375; ***620)
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4.3.2.1.1 Study sample: intrinsic green pigmentation in primary teeth
Twenty children ( 9 males and 11 females) with intrinsic green stain were examined. 
Their mean age was 56 months (range 30 months to 82 months, median 56 months). 
The children in this sample had received a liver graft at a mean age o f 18 months 
(range 7 months to 54 months, median 11 months). Seventeen o f the children had 
suffered from extrahepatic biliary atresia, two had alpha-1-antitrypsin deficiency and 
the remaining child had sclerosing cholangitis.
4.3.2.1.2 Study sample: intrinsic green pigmentation in permanent teeth
Seven children ( 3 males and 4 females) were examined. Their mean age was 107 
months (range 82 months to 138 months, median 108 months). The children in this 
sample had received a liver graft at a mean age o f 36 months (range 7 months to 114 
months, median 23 months).
4.3.2.2 Results
4.3.2.2.1 Intrinsic green pigmentation in the primary dentition
The mean green pigmentation score was 38. The scores ranged from ‘8’ to ‘62’. 
The results confirmed that there was indeed a wide degree o f variation between 
individual children.
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Children with extrahepatic biliary atresia did not appear to have any more severe green 
pigmentation than children who had suffered from alpha-1-antitrypsin deficiency or 
sclerosing cholangitis. Seventeen o f the children had EHBA and the mean 
pigmentation severity score was 38. O f the remaining 3 children, two had alpha-1- 
antitrypsin deficiency and had a mean pigmentation severity score o f 40. The remaining 
child had sclerosing colangitis and also had a mean score o f 40.
A greater degree o f variation in the severity of the green pigmentation was found 
within individual children. In some o f the subjects, the cervical margins o f the primary 
incisor teeth were more deeply stained than the incisal edge. The primary molar teeth 
were found to be more severely stained than the canines and incisors. The primary 
molars had a mean score o f ‘3’, compared to the canines which had a mean score o f 
‘2 ’ and the primary incisors which had a mean score o f 1.2. To highlight this intra­
individual variation further, the sums o f all o f the children’s scores o f severity in 
relation to each primary tooth are shown in the following Figure 7 (a) and (b).
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Figure 7
Composite Intrinsic Green Stain Severity Scores In Relation To The Affected
Primary Teeth
(a)
(b)
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4.3.2.2.2 Intrinsic green pigmentation in the permanent dentition
There was greater variation in the severity o f the green pigmentation amongst the 
seven liver graft recipients who were in the early mixed dentition. The intrinsic 
pigmentation ranged from all o f the teeth scoring ‘1’ to all scoring ‘5’. However, in 
these the molar teeth were found to be only slightly more severely stained than the 
incisors. One o f the affected children is shown in Figure 8 overleaf.
Figure 8
Photograph o f a child in early mixed dentition with intrinsic green pigmentation
This 7 vear-old girl previously suffered from biliary atresia but was not transplanted until she was 3 
years old. She had the worst intrinsic staining, oral hygiene and gingival overgrowth in the entire 
study
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4.3.3 Changes in intrinsic green pigmentation in the primary dentition
4.3.3.1 Methodology
Nine children with intrinsic green pigmentation were re-examined three years after 
their first examination. The teeth that were present were again scored using the 
Intrinsic Green Pigmentation Severity Scale. A total o f 93 teeth were examined, these 
were predominately primary canine and primary molar teeth.
4.3.3.1.1 Study sample
There were 3 males and 6 females. Their ages at the first examination ranged from 10 
months to 5 years 7 months, mean 2 years 10 months. All o f the children had extra 
hepatic biliary atresia. The children had received a liver graft between the ages o f 6 to 
16 months o f age.
4.3.3.1.2 Data analysis
The Wilcoxon Rank Pair test was used to compare between the summed severity 
scores o f each individual at the two examinations.
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4.3.3.2 Results
The statistical analysis failed to show any difference between the intrinsic green 
pigmentation scores obtained at the two examinations. Therefore, the results o f this 
study suggest that the severity o f the green pigmentation does not improve with time.
4.3.4 Reproducibility using the intrinsic green pigmentation scale
Ten children in the primary dentition, were re-examined within 6 months o f the initial 
examination. Cohen’s Kappa statistic was calculated to enable the measure o f 
agreement obtained on the data derived from the colour scale to be measured against 
that which would have been obtained at random.
The study examined both the reproducibility o f the severity o f the intrinsic 
pigmentation in the primary incisors and the reproducibility o f the severity o f the 
intrinsic pigmentation in the primary molars. Any child who had caries or hypoplasia 
in the relevant teeth was excluded.
2.3.4.1 Reproducibility in primary incisors
The teeth o f eight children were included. The kappa score in this study was found to 
be 0.33 indicative o f poor agreement.
2.3.4.2 Reproducibility in primary molars
The teeth o f 7 children were evaluated. The kappa score was found to be 0.6, 
indicative o f substantial agreement.
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4.4
Delayed Eruption of the Primary Dentition in Paediatric Liver
Transplant Recipients
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4.4.1 Introduction
This was a prospective controlled study into delayed eruption o f the primary dentition 
in paediatric liver graft recipients. The aim o f this study was to evaluate the 
contribution o f the underlying liver disease, malnutrition and cyclosporin therapy in the 
aetiology.
4.4.2 Study sample
A total o f 84 children between the age o f 14 months to 36 months were examined by 
the author, after parental consent was obtained, between January 1994 and May 
1996. Fourteen children were later excluded after they were found to be medicated 
with either corticosteroids or nifedipine. None of the subjects were medicated with 
phenytoin. The study sample contained 39 boys and 31 girls.
132
4.4.3 Methodology
All o f the children were examined using dental mirror and a pen torch.
The examination into the prevalence and aetiology o f delayed eruption o f the primary 
dentition was evaluated using two methods:
•  by determination o f the prevalence o f delayed eruption in paediatric liver graft 
recipients compared to control groups with and without underlying liver disease 
with malnutrition.
•  by comparison between the number o f erupted teeth in age- matched pairings 
between subjects from different study groups.
4.4.3.1 Measurement o f the prevalence o f delaved eruption in study and control groups 
The children were grouped as follows:
I. Liver transplant recipients, medicated with cyclosporin, who have malnutrition
II. Liver transplant recipients, medicated with cyclosporin, who are not malnourished
III. Children with liver disease and malnutrition
IV. Children with liver disease with no malnutrition
V. Children with malnutrition with a cause other than liver disease.
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A summary o f  the demographic information from each o f the afore-mentioned study 
groups is shown in the following Table 11.
Table 11
Sum m ary O f Descriptive Inform ation In Each G roup
Descriptive statistics o f subjects in each group / II III IV V
number in each group 7 17 16 21 9
mean age (months) 23 26 23 25 22
mean duration of cyclosporin therapy (months) 11 12 - - -
mean age at OLT 11 13 - - -
mean trough serum cyclosporin level (ng/ml) 151 178 - - -
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4.4.3.2_______The number o f erupted teeth in age- matched subjects
Children from the following groups were then paired as follows:
a) Liver transplantation compared to liver disease ( n=17).
b) Liver transplant recipients with and without malnutrition ( n=7).
c) Liver disease with and without malnutrition ( n=6).
d) Liver disease with malnutrition compared to subjects with malnutrition attributable 
to a cause other than liver disease ( n=7).
4.4.4 Data collection
The nutritional status o f the child was determined using Tanner-Waterhouse growth 
charts (1972) . A child was considered to be malnourished when they were on or 
below two standard deviations o f the normal population height and growth curves, i.e. 
on or below the third percentiles, at the time o f the dental inspection.
The mean o f the last three circulating trough cyclosporin levels was noted for those 
subjects who had received liver grafts.
A primary tooth was scored as present if any part if the crown had emerged through 
the oral mucosa. A child was considered to have delayed eruption if there was more
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than six months delay in primary tooth eruption compared to the modified 
chronological tables o f Lunt and Law ( 1974 ). The appropriate section is summarised 
in the following Table 12.
Table 12
Chronological Table O f Prim ary Tooth Eruption
Maxilla '
. y  . . .  : • • ::::
M andible
.
central incisor 10 8
lateral incisor 11 13
canine 19 20
1 st molar 16 16
2nd molar 29 27
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4.4.5 Statistical analysis
The prevalence o f delayed eruption within groups I, II, III, IV and V was reported. 
The effect o f liver transplantation on the eruption o f the primary dentition was 
measured using the paired t-Test to compare the number o f teeth present between 
subjects with liver grafts without malnutrition and liver disease without malnutrition.
The relationship between the number o f erupted teeth and the mean circulating trough 
cyclosporin level in subjects who had received liver grafts was analysed using Multiple 
Regression Analysis.
137
4.4.6 Results
4.4.6.1 Prevalence o f delaved eruption in study and control groups
The prevalence o f delayed eruption o f the primary dentition in liver graft recipients 
whether they were malnourished or not, was high, at 43% and 47% respectively.
The prevalence o f delayed eruption in each group is summarised in Table 13 below 
and the relative frequency o f delayed eruption within each group is shown 
diagramatically in Figure 9 overleaf.
Table 13
The Prevalence O f Delayed Eruption In Each Study G roup
Group Number of 
Subjects
Number with 
Delayed Eruption
I OLT with malnutrition 7 3
II OLT, no malnutrition 17 8
III Liver Disease and malnutrition 16 2
IV Liver Disease, no malnutrition 21 0
V Malnutrition controls 9 0
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Figure 9
The Prevalence Of Delayed Eruption Of The Primary Dentition In Each Group
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4.4.6.2 Comparison between OLT recipients with and without delayed eruption
Those children with delayed eruption o f  the primary dentition had not only been in 
receipt o f a liver graft for a much longer period o f time but had also been transplanted 
at an earlier age than those without delayed eruption. However, the mean trough 
serum cyclosporin concentrations were lower in the delayed eruption groupings. 
Furthermore, the presence o f malnutrition appeared to have no effect. The comparison 
between the paediatric liver graft recipients who did have delayed eruption o f the 
primary dentition, compared to their peers who did not, in relation to age, age at 
transplant, duration o f cyclosporin therapy and trough cyclosporin level is shown in 
Table 14 overleaf.
Table 14
Comparisons Between Liver Graft Recipients With and Without Delayed
Eruption
GROUP N
Delayed
eruption
Mean
age
(months)
Age at 
OLT
(months)
Cyclosporin
therapy
duration
(months)
Mean trough 
serum 
cyclosporin
(ng/ml)
OLT with 3 Y 23 6 17 126
m alnutrition
4 N 24 16 8 169
OLT w ithout 8 Y 28 12 16 143
m alnutrition
9 N 25 14 9 209
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4.4.6.3 Comparison between the number o f erupted teeth in age-matched subjects
When the number o f erupted teeth was compared in the age-matched pairings the 
children with liver grafts were found to have less teeth than those with liver disease. 
This was confirmed by the paired t-test which showed that there was a significant 
difference between the number o f erupted teeth in children with liver grafts compared 
to children with liver disease, t=2.46, p=0.013 (one tailed).
Due to the small size o f the remaining paired groups no further statistical analysis was 
performed. However, the following results were also found:
•  In liver graft recipients, there was no difference in the number o f erupted teeth 
when those who were malnourished were compared to those who were not.
•  Children with liver disease and malnutrition had more teeth than those with liver 
disease who were not malnourished.
• The children with liver disease and malnutrition had less teeth than those with 
malnutrition attributable to another cause.
•  There was no relation found between the number o f erupted teeth present and the 
circulating cyclosporin level in the two groups o f children who had received liver 
transplants.
The detailed comparison between the number o f erupted teeth in the age-matched 
subjects is summarised in Table 15 overleaf.
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Table 15 Comparison Between The Number Of Erupted Teeth In Age-
M atched G roups
Liver transplant recipients compared to children with liver disease
Age-matched group number mean age 
(months)
mean no. 
teeth
cyclosporin
duration
age at 
OLT
(a) Liver transplant
17 26 13 12 months 13
Liver disease 16 “
Liver graft recipients with malnutrition compared to those without
Age-matched group number mean age 
(months)
mean no. 
teeth
cyclosporin
duration
age at 
OLT
(b)
Liver transplant with 
malnutrition
7 23 11 11.5 months 11.5
Liver transplant w ithout 
malnutrition
11 11 months 12
Children with liver disease and malnutrition compared to those without
Age-matched group number mean age 
(months)
mean no. 
teeth
cyclosporin
duration
age at 
OLT
(C)
Liver disease with 
malnutrition
6 23 14 - -
Liver disease without 
malnutrition
10
Liver disease with malnutrition compared to the malnutrition control group
Age-matched group number mean age 
(months)
mean no. 
teeth
cyclosporin
duration
age at 
OLT
(d )
Liver disease w ith 
malnutrition
7 21 8 - -
Malnutrition only 12 - -
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4.4.6.4 Relation between tooth number and the trough cyclosporin concentration
Multiple regression analysis just failed to show an association between the number o f 
teeth and the trough cyclosporin concentration (R=0.47, F=4.1, significant F=0.06).
j Therefore, the association between the trough cyclosporin concentration and the
|
| number o f erupted teeth was re-analysed using ANOVA with age as the covariant. The
i
I association between the number o f teeth and the trough cyclosporin level was highly
i
| significant when age was controlled statistically (F=5.1 p=0.01) in the children with
j
| liver grafts who were not malnourished.
it
| There was no significant relationship found between the trough cyclosporin
■
concentration and the number o f erupted teeth in the seven children with liver grafts 
who were malnourished.
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4.5
The Effect of Age, Age at Transplantation and Duration of 
Cyclosporin Therapy on Gingival Overgrowth in Children with Liver
Grafts.
4.5.1 Introduction
In view o f the variation in cyclosporin bioavailability with age and the large number of 
babies and infants who have received liver grafts, it is clear that cyclosporin-induced 
gingival overgrowth in relation to age, age at transplantation and duration o f therapy 
merits further investigation. Although the cross-sectional study, which forms the first 
part o f these clinical investigations, was the largest o f its kind ever published, the 
variables in relation to age, age at transplantation and duration o f cyclosporin therapy 
were not controlled.
The aim o f this prospective study was to investigate the effect o f the age o f the child, 
their age at transplantation and the duration o f cyclosporin therapy on the prevalence 
and severity o f gingival overgrowth.
4.5.2 Study sample
A total number o f 184 examinations were carried out in 97 children over a five year 
period. There were 52 females and 45 males and their ages ranged from 6 months to 
17 years.
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4.5.3 Methodology
A dental examination was carried out, by the author, on paediatric liver transplant 
recipients when they attended the Liver Unit for an out-patient review. Children who 
had no erupted teeth, or who were medicated with Neoral cyclosporin or FK506 were 
later excluded.
Children were examined in the dental unit using a dental light source, with the 
exception o f babies who were examined on their parent’s knee with either a dental 
light or a pen torch.
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4.5.4 Data collection
The following information was collected:
• age and sex o f patient
• age at transplant
• time post transplant
• concomitant nifedipine therapy
• serum trough cyclosporin concentration, calculated from that taken on day o f 
examination and on the levels from the previous two blood tests.
• gingival overgrowth was scored as being present or absent in each subject. The 
severity o f the gingival overgrowth was then scored according to the Index o f 
Severity o f Gingival Overgrowth as previously described.
The 184 examinations were then grouped as follows:
•  Age-bands according to age at the time of the dental examination
•  Age-bands according to age at the time of transplantation
• Time-bands by duration o f cyclosporin therapy
Only the last examination recorded if the same subject was examined more than once 
within each study band.
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4.5.5 Statistical analysis
Data were analysed using both the Microsoft EXCEL and SPSSPC statistics packages. 
The association between the level of gingival overgrowth and the trough cyclosporin 
concentration was examined using Analysis o f Variance (ANOVA). A level o f p< 05 
was accepted as statistically significant. Within each study group, Pearson's Product 
Moment Correlation Coefficient was used to evaluate the association between the age 
o f the patients at the time o f the dental examination, their age at transplantation and 
the duration o f cyclosporin therapy with the trough cyclosporin concentration and the 
severity o f gingival overgrowth.
The two sample t-Test was applied, when there was a sufficiently large number o f 
subjects, to measure the association between the trough cyclosporin concentrations in 
those subjects who had gingival overgrowth compared to those who did not. The null 
hypothesis was that there should be no difference between the two groups. A similar 
analysis was applied to assess the relationship between the presence o f gingival 
overgrowth in those who were medicated with nifedipine compared to those who were 
not.
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4.5.6 Results
A summary o f the demographic information in each age band, age at liver 
transplantation and duration o f cyclosporin therapy is shown in Table 16 overleaf.
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4.5.6.1 The effect o f age on cvclosporin-induced gingival overgrowth
Analysis o f variance failed to show any association between the severity o f gingival 
overgrowth and the trough cyclosporin concentration in any o f the age-banded groups.
The Pearsons Product Moment Correlation Coefficient showed that there was an 
inverse correlation between the trough cyclosporin concentration and the duration o f 
cyclosporin therapy in all o f the age-banded groups except in the babies under 1 year 
o f age. The results are summarised in Table 17. There was no significant correlation 
found between the trough cyclosporin concentration and any o f the other variables 
examined.
Table 17
Trough Cyclosporin Concentration Compared To Duration Of Therapy
age~band no. ofsubjects Pearson Product Moment Correlation Coefficient
1-2 years 20 r = 0.65 p = 0.01
2-5 years 18 r = 0.71 p = 0.001
5-10 years 36 r = 0.15 p = 0.001
> 1 0  years 13 r = 0.63 p = 0.05
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There was no association found between the gingival overgrowth severity and any o f 
the other variables. However, in the 5 years to 10 years age-band there was a 
significant difference between the trough cyclosporin concentration in those with 
gingival overgrowth compared to those without (Two-Sample t-Test t= 2.09, two 
tailed critical t=2.03, p< 0.05).
The relation between the gingival overgrowth severity and the mean trough 
cyclosporin concentration in each age-band is shown in Figure 10 overleaf.
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Figure 10
Mean Trough Cyclosporin Concentration and Gingival Overgrowth Severity in
Age-banded Groups
a) Trough cyclosporin concentration (ng/ml) in subjects grouped by age
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4.5.6.2 The effect o f age at OLT on cvclosporin-induced gingival overgrowth
Analysis o f variance failed to show any association between the severity o f gingival 
overgrowth and the trough cyclosporin concentration.
The Pearson Product Moment Correlation Coefficient showed a significant inverse
I association between the trough cyclosporin concentration and the duration o f
i
cyclosporin therapy in subjects who were transplanted at between 3 and 5 years o f 
j  age (r= 0.64 p= 0.01 ) and in those transplanted between 5 and 12 years o f age (r =
t
| 0.67 p= 0.01).
| There was no association found between the severity o f gingival overgrowth and any
j o f the other variables.
i
i
The relation between the gingival overgrowth severity and the mean trough 
cyclosporin concentration in each OLT age-band is shown in Figure 11 overleaf.
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Figure 11
Mean Trough Cyclosporin Concentration And Gingival Overgrowth Severity In
Groups Banded By Age At OLT
a) Mean trough cyclosporin concentration (ng/ml) in children grouped by age at OLT
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4.5.6.3 The effect o f duration o f cyclosporin therapy on gingival overgrowth
Analysis o f variance failed to show any association between the severity o f gingival 
overgrowth and the trough cyclosporin concentration in any o f the groups, banded 
according to cyclosporin therapy. Furthermore, no association was found between 
either the severity o f gingival overgrowth or the trough cyclosporin concentration and
[ any o f the other parameters within the groups. There was no difference found in the
I
| cyclosporin concentrations between those who had gingival overgrowth compared to
I[
those who had not when the t-Test was applied.
The relation between the gingival overgrowth severity and the mean trough 
cyclosporin concentration in each group, banded by duration o f cyclosporin therapy, 
is shown in the following Figure 12.
I
fI
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Figure 12
Mean Trough Cyclosporin Concentration And Gingival Overgrowth Severity In
Groups Banded By Duration Of Cyclosporin Therapy
a) Mean trough cyclosporin concentration (ng/ml) in children grouped by
duration o f cyclosporin therapy
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4.5.7 Effect of nifedipine on the presence and severity of gingival overgrowth
The association between nifedipine medication and the presence o f gingival 
overgrowth was analysed in the group o f subjects who were medicated with 
cyclosporin for less than 1 year. The two -Sample t-Test ( assuming equal variance) 
failed to show any difference between gingival overgrowth severity in those medicated 
with nifedipine compared to those without ( t = 1.55, one tailed critical t = 1.67, p> 
0.05) .
The relation between gingival overgrowth severity and concomitant nifedipine 
medication was evaluated in the group o f subjects who were aged between 13 months 
and 24 months. This group was selected because they were a large group with 50% 
with gingival overgrowth and 50% medicated with nifedipine. The contingency 
coefficient showed that there was no significant relationship (p= .55) between the 
severity o f gingival overgrowth and nifedipine therapy. The data in relation to the 
nifedipine therapy and gingival overgrowth are shown in Table 18.
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Table 18
Contingency Table Of Gingival Overgrowth Compared To Nifedipine 
Medication In Subjects Transplansplanted For Less Than 1 Year.
Gingival Overgrowth / 
nifedipine therapy
Y N
0 4 6
1 3 1
2 2 3
3 1 0
4 0 0
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4.5.8 The relation between gingival overgrowth and delayed eruption.
O f the 97 children who were studied, 47 were below 5 years o f age. Sixteen had 
delayed eruption o f the primary dentition according to the criteria from the previous 
paper. Within this group, the prevalence o f gingival overgrowth was 78% .
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4.6
The Influence of Cytomegalovirus on Cyclosporin-induced Gingival
Overgrowth
162
4.6.1 Introduction
The aim o f this study was to examine the effect o f cytomegalovirus on cyclosporin- 
induced gingival overgrowth in children who have received liver grafts.
Since the susceptibility to CMV disease is known to be greatest following primary 
infection, the CMV status together with the diagnostic classification o f primary 
infection, secondary infection and reactivation will be evaluated.
4.6.2 Study sample
Fifty-nine children taking cyclosporin (Sandimmune macromulsion preparation) 
following liver transplantation were examined in the dental surgery.
There were 29 males and 30 females, mean age 3yrs 9months (range from 9 months 
to 12 yrs). The mean time post transplant was 1 year 5 months (range 1 month to 4yrs 
7months). Thirty-one o f the 59 children (53%) received grafts from seronegative 
donors and the remaining 28 children (47%) received grafts from seropositive donors. 
The CMV status prior to liver transplantation was available for 58 o f the 59 patients. 
Forty-two (75%) o f these children were CMV seronegative before liver transplantation 
and 16 (26%) were seropositive. There were 21 children who were CMV seronegative 
prior to transplant who received CMV seropositive transplants. Following liver 
transplantation, at the time o f the dental examination, 32 ( 54%) children were CMV 
seronegative and 27 (46%) were CMV seropositive.
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4.6.3 Methodology
The CMV status of the patient prior to liver transplantation was previously recorded 
on the Liver Unit Data Base and was matched retrospectively to the findings in the 
dental examination. It was possible to obtain an exact match between the CMV data 
and the dental findings since the dental examinations always coincided with the Liver 
Unit out-patient visit. Subjects in which there was found to be mis-matched data had 
been previously excluded.
4.6.3. 1_______Measurement o f trough cyclosporin concentration
The circulating trough cyclosporin concentration was taken as the mean o f the 
previous three blood tests.
4.6.3. 2______ Measurement o f gingival overgrowth
Gingival overgrowth was scored as being present or absent and the Index o f Severity 
o f Gingival Overgrowth, which was used in the first study and was shown in Table 8 
was used to record its severity.
4.6.3. 3______ CMV status
Patients were deemed to be CMV seropositive if either IgM and/ or IgG was detected 
in serum by enzyme-linked immunosorbent assay (ELISA). The presence o f CMV 
inclusion bodies or an inflammatory cell infiltrate was not examined since in this study
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population it was not appropriate to perform gingival biopsy. Reactivation o f CMV 
was diagnosed where IgM was found in a child who previously had IgG. Primary 
infection was diagnosed when IgM was found in a previously IgG and IgM negative 
child. These diagnostic criteria are shown more fully in the Table 19 following.
Table 19
CMV Diagnostic Classification
CM V Status pre OLT Diagnostic Classification Imm une Response
positive reactivation increasing IgM titres
positive no reactivation no IgM
negative primary infection increasing IgM titres
negative secondary infection IgM +ve for second time
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4.6.4 Statistical analysis
The SPSS computer software package was used to perform the statistical analysis.
The analysis was performed as follows:
1) Association between gingival overgrowth and the diagnostic classifications o f CMV 
infection.
2) Comparison between gingival overgrowth and CMV status after transplantation.
3) Comparison between gingival overgrowth and the status o f the host before 
transplantation.
4) Comparison between host CMV status before and after transplantation in respect o f 
gingival overgrowth.
5) Association between gingival overgrowth and the CMV status o f the liver graft.
6) Comparison between subjects with latent or reactivated CMV infection compared 
to subjects who have never been exposed to CMV.
The association between the presence and severity o f gingival overgrowth and CMV 
status was examined by the Chi-square test and by the Contingency Coefficient 
respectively.
ANOVA was used to evaluate any association between the circulating cyclosporin and 
the level o f gingival overgrowth. The Student t-Test was used to examine the 
difference in circulating cyclosporin levels between those who had gingival overgrowth 
present and those who did not.
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4.6.5 Results
4.6.5.1 Cvclosporin-induced gingival overgrowth
| Thirty-one (53%) children had no gingival overgrowth. Of the 28 (47%) who did;
| twelve scored ‘1* on the Index o f Severity, nine scored ‘2’, and seven scored ‘3’.
f
[
These findings, represented as the frequency at which each severity level o f gingival 
overgrowth was found in the study population, are shown in Figure 13. There was no
II
! relation between CMV positive and CMV negative recipients and the presence o f 
gingival overgrowth [Chi-squared = 0.2, p = 0.989]. The comparison between the
I
| CMV status o f the recipients and the severity o f gingival overgrowth is summarised in
I Table 20.
Figure 13 
Gingival Overgrowth Severity
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Table 20
Comparison Between CMV Positive And CMV Negative Recipients
CM V positive
(27 recipients)
CM V negative
(32 recipients)
imean serum  cyclosporin (ng/ml) 157.6 166.6
INo. children with gingival overgrowth 13 (48%) 15 (47% )
severity  of gingival overgrow th: 0 14 17
1 6 6
2 4 5
3 3 4
4 0 0
168
4.6.5.2 Gingival overgrowth and the diagnostic classification o f CMV infection
There was no relationship found between the severity o f  gingival overgrowth and a 
diagnosis o f primary CMV infection, reactivation or secondary infection (contingency 
coefficient 0.38).
The comparisons between CMV status and the presence o f gingival overgrowth are 
shown in Table 21 below.
Table 21
Gingival Overgrowth Com pared To CM V Status
CM V status num ber of children num ber w ith gingival 
overgrowth
reactivation 1 0
no reactivation 6 3 (50%)
primary infection 17 8 (47%)
secondary infection 2 2(100% )
negative 32 15 (47%)
4.6.5.3 Comparison between gingival overgrowth and CM V status after OLT
Irrespective o f  CMV status prior to transplantation, for all o f  the 59 children 
examined, no significant association was found between CMV status following 
transplant and either the presence (Chi-square 0.01 p= 0.99) or the level o f  severity o f 
gingival overgrowth (contingency co-efficient 0.16).
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4.6.5.4 Gingival overgrowth and the CMV status o f the host before OLT
There was no relation between CMV status prior to transplant and either the presence 
(Chi-square 0.23 p= 0.98) or the severity o f gingival overgrowth (contingency 
coefficient 0.16).
4.6.5.5 Gingival overgrowth and host CMV status before and after transplantation
Following transplantation, recipients who had been seronegative before transplantation
i
| (n=42) showed no significant association between their CMV status at the time o f the
| dental examination and the presence o f gingival overgrowth (Chi-square 0.002 p=
0.96). Similarly, in recipients who had been seropositive before transplantation (n=14) 
there was no significant association found between the presence o f gingival
I
| overgrowth and the CMV status following transplantation (Fishers exact test 1 tailed ,
|
0. 121).
ii
j
| 4.6.5.6 Association between gingival overgrowth and CMV status o f the liver graft
No relation was found between the CMV status o f the donated liver and either the 
presence (Chi-square 0.23, p= 0.63) or the severity o f the gingival overgrowth 
(contingency coefficient 0.16).
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4.6.5.7 Comparison between subjects with latent or reactivated CMV infection 
compared to subjects who have never been exposed to CMV
When subjects who had latent or reactivation o f CMV were grouped together and 
compared against those children who were never been exposed to the virus. The 
presence o f gingival overgrowth was not related to either seropositive recipients o f 
seropositive transplants (n=4) or seronegative recipients o f seronegative transplants 
(n=21), (Chi-square 0.21 p=0.65). Moreover, there was no relation between any o f 
the above and the severity o f the gingival overgrowth (contingency coefficient 0.4).
4.6.5. 8______ Cyclosporin and gingival overgrowth
The mean circulating cyclosporin level was 162.51 ng/ml (n= 58, range 0 to 
413ng/ml). There was no significant association between the level o f  circulating 
cyclosporin and either the presence or severity (ANOVA F=.52, p= 0.67) o f  gingival 
overgrowth. There was no difference in the circulating cyclosporin level between those 
who had gingival overgrowth and those who did not (Student t-Test, t=0.9, p= 0.67). 
The mean circulating cyclosporin level was 168 ng/ml in the 31 patients who were 
CMV seronegative following transplantation and was 157 ng/ml in the 27 patients 
who were seropositive following transplantation. There was no difference between the 
trough cyclosporin concentration o f those who were CMV seropositive and those who 
were seronegative (Student t-Test, t= .54, p= 0.59).
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Chapter Five
Discussion
172
5.1 Methodology
5.1.1 Study Design
The design o f these clinical studies was constrained by the distance that many o f the 
children with liver grafts had to travel to attend Birmingham Childrens Hospital. It was 
impractical to recall specific subjects for the purpose o f a dental examination alone. 
Therefore, throughout the course o f this study the examinations had to  be carried out 
in conjunction with an out-patient appointment in the Liver Unit.
In the first year or so post-transplantation the children attend the Liver Unit relatively 
frequently. However, once their cyclosporin levels have been stabilised, in the absence 
o f further complications, the children are managed by their local paediatric 
gastroenterologist. Indeed, many o f these children only attend annually for what is 
generally described as their ‘M .O.T’.
Initially, the author had hoped to examine all o f the subjects longitudinally at 3, 6 and 
then 12 monthly intervals but since the children were all at different stages post­
transplant, and therefore attending at varying frequencies, this was only partially 
successful in the younger age groups. Similarly, although separate cohorts o f children 
were identified in relation to age, liver disease and age at transplantation, it eventually 
proved impossible to carry out the dental examination at the preordained times,
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particularly in the older children. Therefore, it was more difficult to measure the 
changes in gingival overgrowth severity and intrinsic pigmentation longitudinally.
The repeat examinations to confirm the reproducibility o f the data obtained using the 
gingival overgrowth and intrinsic pigmentation scales had to be carried out within a 
short time o f the initial exam. Otherwise, the results could have been confounded with 
increased severity o f gingival overgrowth, with duration o f cyclosporin therapy, as 
reported by Seow et al (1991), and by fading o f the intrinsic staining as suggested by 
Marsland and Gerrard (1953). Therefore, although it would have been more powerful 
to carry out the reproducibility studies using samples that more closely matched those 
o f the main investigations, this was precluded by the supra-regional nature o f the liver 
Unit in Birmingham.
5.1.1.1 Measurement o f gingival overgrowth severity
The measurement o f gingival overgrowth severity could be related to the study o f 
Lowry et al (1995) into the oral effects o f paediatric cardiac transplantation. Indeed, 
the authors were in correspondence throughout the period o f this study in regard to 
the measurement o f gingival overgrowth. Both studies had similar difficulties in 
establishing objective measurement o f gingival overgrowth severity. These difficulties 
arose because both researchers found that it was impossible to take alginate 
impressions in the very young children, and so could not follow the objective criteria
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for measuring gingival overgrowth severity that were published by Seymour et al 
(1985).
This study had an even younger sample population than the previously mentioned 
study by Lowry et al (1995). Therefore, the measurement o f gingival overgrowth 
severity used in this study was a simple estimation o f the amount o f crown covered 
and was suggested by Professor Seymour himself in a personal communication.
This study found that the reproducibility o f the gingival overgrowth severity data, 
obtained using the Index o f Gingival Overgrowth Severity, showed only moderate 
agreement between dental examinations that were one month apart (Landis and Koch 
1977). However, the majority o f children in this study, were in the primary dentition. It 
is possible that the reason why only moderate agreement was found is that these results 
were a reflection o f the difficulty in evaluating gingival overgrowth accurately in 
partially erupted, and worn, primary teeth. There may also have been an actual change 
in the gingival condition over the month time interval.
Seow eta l (1991) only reported the gingival overgrowth as being ‘mild to severe ’ . On 
the other hand, Ross et al (1989) measured gingival width using a periodontal probe 
that was placed at the maximum tooth bulbosity on the buccal and lingual aspects 
perpendicular to the long axis o f the tooth. However, the average age o f their study
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group was 8 years compared to a mean age o f 4 years 8 months in the cross-sectional 
study and 5 years 3 months in the reproducibility study.
Funakoshi et al (1992) used a Gingival Enlargement Index, which measures interdental 
enlargement on the buccal and lingual aspects of the incisors and both posterior 
segments in both arches. Their study had five subjects with ages ranging from 3 years 4 
months to 5 years 6 months and, as such, is the nearest comparable to this study. 
Although the use o f the same scale was considered for this study it was rejected 
because not all the subjects in this study had a full dentition and because the scale was 
considered to be not sufficiently sensitive, since the gingival overgrowth could be seen 
to be present even when there was no obvious interdental enlargement.
Perhaps a three point, rather than a four point scale, would have been more efficacious 
to use in a population with a large number o f children with primary teeth. A possible 
example o f a three point scale that might be a more reproducible measure o f gingival 
overgrowth in the primary dentition is as follows:
1. gingival overgrowth detectable
2. gingival overgrowth covering between one half and over o f the clinical crown but 
with the crown still visible
3. gingival overgrowth covering all o f the o f the clinical crown in a tooth that had 
previously emerged’
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However, before this scale can be used it must also be tested clinically to evaluate its 
reliability, sensitivity and reproducibility.
5.1.1.2 Measurement o f enamel hypoplasia
The evaluation o f enamel hypoplasia used the Thylstrup and Fejerskov Index (1978). 
This scale was chosen because it was simple to use and had been found to be effective 
in a pilot study o f ten children with liver grafts that had been carried out in 1990. This 
index has been extensively used in epidemiological investigations o f mottling, 
particularly in relation to fluorosis and is a well accepted reproducible system.
5.1.1.3 Measurement o f intrinsic green pigmentation
The Intrinsic Green Pigmentation Colour Scale was developed to facilitate a more 
accurate recording o f the intrinsic pigmentation than had previously been reported in 
this population.
Funakoshi et al (1992) merely reported that ‘discolouration was observed\  The 
publication by Seow et al (1991) gave a more detailed description, reporting that the 
colour ranged from yellow-brown to deep green with variation between patients. 
Marsland and Gerrard (1953) had suggested that the colour changed with time. 
Therefore, the author felt that the evaluation o f the intrinsic green pigmentation had to
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be as objective as possible to allow more accurate reporting and observation o f any 
colour change. Since there were no known dental shade guides that had green 
pigmentation the development o f a novel colour scale was the only option.
The evaluation o f the reproducibility o f the data based on the colour scale showed that 
the data from the primary incisor measurements were much less reproducible than that 
obtained from the primary molar teeth. A possible explanation for this finding is that a 
smaller proportion o f the primary incisor crown is stained compared to the primary 
molars. However, the clinical crown o f the primary incisors is often reduced in size due 
to attrition and gingival overgrowth and this might add to the difficulty in obtaining 
accurate measurements o f intrinsic pigmentation.
5.1.2 Study samples
5.1.2.1 Cross-sectional study
The study sample in the cross-sectional study was far larger than other studies into 
paediatric liver transplantation, such as those o f Ross et al (1989), Funakoshi et al 
(1992) and Seow et al (1991). The results were also representative o f a much 
younger population than had previously been reported; not only was the mean age of 
the children 4 years 8 months but the median was only 3 years 8 months. Owing to the 
increasing availability o f liver grafts to babies and infants this sample probably gave a 
more accurate overview of the oral effects of paediatric liver transplantation.
5.1.2.2 Intrinsic green pigmentation study
The number o f children with intrinsic green pigmentation was surprisingly small since 
previous investigators had suggested that there was a very high prevalence o f intrinsic 
green pigmentation in this population. This was particularly apparent in the difficulties 
that arose in finding a large enough group o f liver graft recipients with intrinsic 
pigmentation o f the permanent dentition.
However, the difficulty in collecting a sufficiently large sample o f children with 
pigmented permanent teeth should not be interpreted as confirmation that the 
prevalence o f green pigmentation in the permanent dentition is likely to be small.
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Instead, the scarcity o f numbers is more likely to be due to the fact that intrinsic green 
pigmentation is almost entirely confined to children with biliary atresia. It is only in the 
last few years, with the introduction o f the split liver procedure, that babies with biliary 
atresia can be offered a liver graft. Therefore, this particular investigation was ahead 
o f its time and, should it be repeated in five years time, suitable subjects might be 
more easily obtained.
5.1.2.3 Delayed eruption study
When this study was being designed the liver team and the dietetic department were 
convinced that there would be sufficient children with malnutrition to make up the 
control groups. However, collecting subjects who satisfied the criteria for inclusion 
into the malnourished groups was an extremely difficult and time-consuming part o f 
this entire dissertation.
It is interesting to note that Reilly et al (1992) reported that less than 20% o f the 
children in their study who were on or below the third percentile for weight at 12 
months o f age were referred to a paediatrician. Furthermore, their study into primary 
tooth eruption in failure-to-thrive infants found only 47 suitable subjects out o f a 
population o f 2608 (Reilly et al 1992).
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Perhaps the inclusion criteria o f on or below the third percentile were too severe, for 
both height and weight, but selecting only those children who were outwith two 
standard deviations o f the normal will allow comparisons between this and future 
investigations. If  the inclusion criteria had extended to all o f those children who were 
diagnosed as ‘failure to thrive’ this would have produced a very diverse group of 
individuals indeed. Moreover, since it is not clear whether it is acute or chronic 
malnutrition that has the greatest effect on the developing dentition, only including 
subjects who were below both height and weight parameters eliminated any ambiguity.
The low prevalence o f delayed eruption in the two control groups, namely those with 
liver disease and malnutrition and those with malnutrition o f non-hepatic origin is 
surprising, in view o f previous publications but might be attributable to the small 
sample sizes. However, the number o f subjects in this study is comparable to some o f 
these other publications, most notably is Alvarez et al ( 1989 )who only had seven 
subjects who were actually ‘stunted and wasted’.
5.1.2.4 Effect o f age and duration o f cyclosporin on gingival overgrowth
Despite the size o f the sample in the cross-sectional study, it was dominated by pre­
school children, and although it gave an accurate overview o f the prevalence of 
gingival overgrowth in paediatric liver graft recipients it did not allow an accurate 
evaluation o f the effect o f age and o f duration o f cyclosporin therapy on the gingival 
tissues. Therefore, the fourth study was designed to give a more even age distribution
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within the sample. That investigation clearly showed that there is an increasing 
prevalence o f gingival overgrowth with age and with duration o f therapy. It is likely 
that the reason why previous researchers have reported much higher prevalences o f 
gingival overgrowth than was found in the cross-sectional study is that their samples 
were small and had predominantly older children. The mean age o f the 21 children in 
the study by Ross et al (1989) was 8 years.
The study by Funakoshi et al (1992) contained five children who were aged between 3 
years 4 months and 5 years 6 months and, as such, is more closely comparable to this 
investigation. However, Funakoshi et al (1992) found gingival overgrowth in all o f 
their subjects compared to 39% in this study in the 2 to  5 year age band. Furthermore, 
the photograph in their publication was o f the second most severe case in their sample 
and showed a child with severe gingival overgrowth comparable to that seen in this 
study in only one child throughout the course o f five years. It can only be assumed that 
there is considerable individual variation between children o f similar ages and 
underlines the necessity for largest possible sample size.
5.1.2.5 Effect o f CMV on gingival overgrowth
The subjects in this investigation were part o f a larger sample, selected at random 
from the authors data base after the presence and severity o f the gingival overgrowth 
had already been recorded. In this way the author had no prior knowledge o f the CMV 
status of the subjects. Each subject’s name, hospital number and the date at which the
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dental examination had been performed was then given to Dr. Davison who matched 
these with the CMV status recordings in the liver unit data-base.
The sample in this investigation is comparable to that in the cross-sectional study but 
had a better balance between males and females and between those with and without 
gingival overgrowth. The number o f children who were CMV seropositive following 
transplantation was 46%. The prevalence o f CMV infection following liver 
transplantation in children who were transplanted in Birmingham has already been 
reported to be 38% (Davison et al 1993).
j
\ After the CMV status data were added to the dental examination report it became clear
that there were very few children with reactivation or secondary infection. The sample 
size was already considerable and due to its retrospective nature it would have been 
difficult to select further subjects who were known to have reactivation or secondary 
infection since the dates at which they had seroconverted might not have been easily 
matched to a dental examination and it would have been difficult to ensure that the 
investigators remained ‘blind’. Furthermore, it was already very clear from the results
| that CMV infection had little significant influence on cyclosporin-induced gingival
|
[ overgrowth and so a trawl o f both data bases for suitable subjects was not carried out.
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5.2 Enamel hypoplasia in paediatric liver graft recipients
This study found that the prevalence o f enamel hypoplastic defects in paediatric liver 
graft recipients was only 11%. This is much less than had hitherto been expected, 
based on the evidence o f the report o f Seow et al (1991). This low prevalence is even 
more surprising given that only 15 % of the children in this study live in the West 
Midlands which is fluoridated.
The examination o f the children in this study was carried out in good light but the teeth 
were not dried, nor were they always inspected with a probe. However, it was felt that 
the examination was sufficiently thorough to record clinically significant defects.
Seow, Shepherd and Ong (1991) reported that enamel hypoplastic defects were found 
in all o f the subjects in their sample who had received liver grafts; a total o f 7 with ages 
ranging from 1 year 8 months to 3 years 11 months. They made a diagnosis o f enamel 
hypoplasia if there was any missing enamel or a break in the continuity o f the enamel 
surface and reported that enamel hypoplasia was found on all o f the erupted teeth o f all 
o f the subjects. They further reported that the hypoplastic defects were only present on 
those parts o f the enamel formed after birth.
The findings in this study and those by Seow et al (1991) highlighted above, appear to 
be conflicting. However, a possible explanation o f the discrepancy might lie in the fact 
that all o f the subjects in the study by Seow et al with one exception, had heights at or 
below the third percentile. Alvarez et al (1993) found that subjects who had suffered
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from chronic malnutrition not only had delayed eruption but also had a high prevalence 
o f dental caries and the authors attributed the latter to the deleterious effect o f 
malnutrition on enamel formation in early life. Based on this knowledge, it is possible 
that the aggressive nutritional support that is undertaken in Birmingham has effectively 
reduced the likelihood that defects o f the enamel would occur.
A recent investigation by Noren et al (1993) suggested that enamel hypoplasia could 
be attributed to oral intubation. Therefore, it is possible that the high prevalence o f 
enamel hypoplastic defects reported by Seow et al (1991) is related to oral intubation. 
However, the subjects in this study also receive frequent general anaesthetics for 
endoscopy and liver biopsy.
Moreover, in view o f the fact that the largest proportion o f the enamel o f the primary 
dentition is calcified in utero, any report o f widespread postnatally acquired defects o f 
the enamel o f primary teeth must be considered dubious. Indeed, in a study into the 
prevalence o f enamel hypoplasia in Mexican children, Goodman et al (1987) found 
that only 6 .1% o f the completely erupted and unworn primary teeth were hypoplastic.
Defects on the enamel o f the permanent teeth could be expected to be more common. 
Indeed, the position o f the enamel hypoplastic lesions in the three children with 
affected permanent incisors corresponded to the stage o f dental development at the 
time of transplant. However, the photograph o f the most severely affected child has an 
appearance that is more suggestive o f endemic enamel fluorosis than o f chronological 
enamel hypoplasia.
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It is clear that further study is required, to evaluate the true effect that paediatric liver 
transplantation has on the enamel o f children who receive a liver graft between birth to 
six years o f age.
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5.3 Intrinsic green pigmentation
5.3.1 Prevalence o f intrinsic green pigmentation in paediatric liver graft recipients
Intrinsic green pigmentation is commonly found in paediatric liver graft recipients. This 
study confirmed that the prevalence o f intrinsic green pigmentation in this population is 
in excess o f 50%. The high prevalence of intrinsic pigmentation is not due to the liver 
transplantation procedure itself. Instead, it is a reflection o f the high number o f 
children suffering from biliary atresia who are now more likely to survive due to the 
increasing availability, and better survival rate, o f paediatric liver transplantation.
5.3.2 Variation in the severity o f the intrinsic pigmentation
Seow eta l (1991) reported that the intrinsic pigmentation in the primary teeth o f liver 
graft recipients ranged from yellowish-brown to deep green, with varying colour 
intensity in each patient. The present study also confirmed that some children are more 
severely affected than others and that the primary molar teeth do indeed appear to be 
more severely pigmented than the primary incisors. The pigmentation in the primary 
incisors o f the subjects in this study was found to be mainly concentrated around the 
cervical area o f the crown. In contrast, a larger proportion o f the crown o f the primary 
molar teeth was pigmented and this pigmentation was more evenly distributed. These 
findings were consistent with the report by Rosenthal et al (1985) in which they 
described the green pigmentation as becoming more vivid and noticeable as the depths 
o f  the cavity preparation extended.
The findings in this present study are also very similar to the variation and extent o f the 
intrinsic pigmentation that was reported by Tank in 1951 in an investigation into green 
pigmentation o f the primary dentition in two children with haemolytic disease o f the 
new-born.
These clinical findings suggest that the green pigment was laid down in an incremental 
pattern. Moreover, the pigmentation in the primary incisors appears to have been 
predominantly deposited around the cervical portion o f the crown, an area that is 
formed in the immediate postnatal period. However, this hypothesis needs to be tested 
further in vitro.
5.3.3 The chronology o f intrinsic green pigmentation in primary teeth
The area o f pigmentation in the cervical area o f the crown o f the exfoliated teeth that 
were presented in this study is calcified shortly after birth, according to Lunt and Law 
(1974). Therefore, the present study found no evidence that bilirubin was deposited in 
utero.
Nevertheless, many o f the children in this study also appeared to have intrinsic green 
pigmentation from the incisal edges to the gingival margins. However, this appearance 
might have been due to the reflection o f green pigmentation from both the cervical 
area o f the crown and the surface o f the root. Indeed, Seow at al (1991), Van Cleynen 
and Demars-Fremault (1990), and Shapiro et al (1975) all presented photographic
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evidence showing severe intrinsic green pigmentation in primary incisor roots. This 
explanation might also be the reason why it was difficult to accurately measure the 
severity o f the pigmentation in the primary incisors of the subjects in the present study.
5.3.4 Variation in the green pigmentation with time
The results in the present study show that the severity o f the intrinsic green 
pigmentation in the primary teeth did not lessen with time. This suggests that the green 
pigment is bound to the dental tissues and adds further weight to the hypothesis that it 
is deposited incrementally rather than by diffusion.
However, Thursfield (1912) clearly reported that primary teeth which had been a vivid 
yellow in colour had later become green and that the tint varied considerably between 
bright and dull. At the same Royal Society meeting in 1912, Langmead (1912) also 
reported that the pigmentation o f the primary teeth in a jaundiced child was seen to 
change from yellow to green. The ensuing discussion at the Royal Society has also 
been published, and chromogenic bacteria were one o f the explanations that were put 
forward for the colour change.
In addition, Marsland and Gerrard (1953) noted that the pigmentation was always 
brightest when the tooth first erupted and then faded as the child grew older. They 
even noted that at the time the tooth had exfoliated it often appeared to be free o f 
pigment altogether. This latter finding was confirmed in the present study since, when
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the exfoliated primary teeth were received they did indeed appear to be much less 
severely stained than expected.
Nevertheless, the present study has shown that it is difficult to accurately quantify the 
severity o f the pigmentation in primary incisors even with the use o f a colour scale. 
However, the study sample used to evaluate colour change in this study, was 
predominantly composed o f primary molar teeth that were not close to exfoliation. 
Therefore, it is possible that this and the other previous studies, rather than reporting 
conflicting results, have demonstrated that the severity o f the pigmentation in the 
primary incisors becomes more severe during root formation and then fades during 
root resorption. As such the green colour in the primary incisors is partially reflected 
from the root. This same colour change is less likely to be seen in pigmented primary 
molar teeth since a larger proportion o f the clinical crown is pigmented.
5.3.5 Intrinsic green pigmentation in the permanent dentition
The intrinsic pigmentation in permanent incisors and first molars in the present study 
showed more homogeneity than was found in the subjects with primary teeth. The 
evaluation o f intrinsic pigmentation in permanent teeth was too limited to put forward 
any other hypotheses. However, based on the evidence presented in the study as a 
whole it is likely that the green pigmentation in permanent teeth will be almost entirely 
confined to those with biliary atresia. It is likely that the deposition o f the pigment will 
be incremental in nature corresponding to the jaundiced period and will not fade with 
time.
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5.3.6 Further study
It is clear that a larger study to carry out a histologic examination o f primary incisor 
teeth is required since the incremental pattern o f deposition o f the intrinsic green 
pigment needs to be confirmed.
The previous publications are predominantly clinical in nature and there is no published 
evidence to show how the pigment is incorporated into the enamel and dentine during 
matrix formation. There are many questions that have still to be answered. In vitro 
investigations will be useful to determine if the pigment is truly biliverdin, if  it can bind 
to hydroxyapatite, if it can diffuse through the dentine and enamel and if it is water 
soluble whilst present in the tooth tissue. In addition, the storage media and sectioning 
methodology have still to be ascertained.
Nevertheless, in the light o f the findings in this study, it is likely that the permanent 
teeth in children with liver grafts who suffered from biliary atresia will have intrinsic 
green pigmentation. Therefore, the efficacy o f operative techniques and new and 
existing dental materials to camouflage the green pigmentation will soon need to be 
explored.
5.4 Delayed eruption in the primary dentition
5.4.1 Prevalence
Both the cross-sectional study and the controlled study have confirmed that 
prevalence o f delayed eruption o f the primary dentition in paediatric liver graft 
recipients is in excess o f 40%. The only other study which reported delayed primary 
tooth eruption in this population was Seow et al in 1991.
5.4.2 Delaved eruption in relation to malnutrition
The present study has shown that children with liver grafts and malnutrition not only 
had a similar prevalence o f delayed eruption but also had the same number o f teeth as 
those with liver grafts who were not malnourished. Therefore, these findings suggest 
that the high prevalence o f delayed eruption o f the primary dentition in paediatric liver 
graft recipients cannot be attributed to poor nutrition alone.
Moreover, if malnutrition had been the most significant factor in the aetiology o f 
delayed eruption in the liver transplant groups, the malnourished controls would have 
been expected to have had a higher prevalence o f delayed eruption or much fewer 
teeth. These findings are surprising in the light o f previous publications but it is 
possible that the influence o f nutritional status on the eruption o f the primary dentition 
has been over-estimated.
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Almost every study into the relation between dental development and nutritional status 
| has shown that primary tooth eruption is significantly delayed in malnourished children 
( Alvarez et al 1989a: Alvarez et al 1992b: Reilly et al 1992). However, these studies 
| based their findings only on the comparison between the number o f teeth present in
the malnourished population sample and the age-matched controls.
In the present study, the subjects were also assessed according to whether or not they 
met the criteria for a diagnosis o f delayed eruption. These criteria, for the diagnosis o f
\
\
I
delayed eruption, required an elapse o f a six month period beyond the eruption dates 
o f Lunt and Law (1974). Therefore, it is conceivable that the subjects with 
malnutrition in the previous studies may indeed have had fewer teeth but might not 
always have been diagnosed as having delayed eruption, had the same diagnostic 
criteria been applied.
Furthermore, although other investigators have reported that there is no clear evidence 
j  that mild-to moderate protein malnutrition influences primary tooth eruption, it has
been suggested that severe malnutrition may have an effect (Delgado et al 1975).
5.4.3 ‘Catch-up’ growth in primary tooth eruption
The subjects in this study did not appear to exhibit ‘catch-up’ growth in relation to 
primary tooth eruption following receipt o f a liver graft.
193
Dental development has previously been reported in association with somatic ‘catch­
up’ growth. Loevy et al (1989) demonstrated that delays in dental eruption are 
corrected during the second year o f development in children who were bom with very 
low birth weights. These findings were confirmed by a later study by Fadavi et al 
(1992) who showed that low-birth-weight, premature children have delayed eruption 
o f the primary dentition only in the first 24 months o f life.
‘Catch-up’ in somatic growth has already been reported in paediatric liver graft 
recipients within twelve months o f liver transplantation (Beath et al 1993b). Both the 
present study and this study, by Beath et al (1993b) were conducted in the Liver Unit 
in Birmingham and, as such, the two study samples contain many o f the same subjects. 
Therefore, one would have expected to find delayed emption only in the children who 
had most recently received a liver graft. However, in this investigation the children 
with delayed emption had been in receipt o f a liver graft for longer than those who did 
not have delayed emption.
5.4.4 Delaved primary tooth emption and liver disease
The subjects with liver grafts had a much higher prevalence o f delayed emption than 
those with an underlying liver disease. Moreover, liver graft recipients were found to 
have significantly fewer teeth than those with liver disease, when the number o f 
empted teeth was compared between age-matched subjects. These findings suggest
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that the underlying liver disease has only a small influence on the aetiology o f delayed 
eruption of the primary dentition in liver transplant recipients.
Nevertheless, none o f the children with liver disease who were well nourished were 
found to have delayed eruption, whereas those who were malnourished had a higher 
prevalence o f delayed eruption than the control group. Therefore, children with liver 
disease might only have an increased propensity for delayed eruption o f the primary 
dentition when the disease is associated with severe malnutrition.
It has already been shown that children with liver disease have a higher than average 
nutritional requirement and they already suffer from defective protein and fat 
metabolism. The combined effect o f these two factors is likely to magnify the severity 
o f the malnutrition found in these subjects (Moukarzel 1990: Beath et al 1993 b).
Therefore, there are two possible explanations for the higher prevalence o f delayed 
emption in subjects with liver disease and malnutrition
•  Children with liver disease who are malnourished probably suffer from a nutritional 
deficiency from birth, and so, this has an earlier and more prolonged effect on the 
development o f the dentition.
•  The malnutrition found in children with liver disease is likely to be more severe 
than malnutrition caused by breast-feeding failure, errors in the formula, chronic
infection and congenital heart disease and, therefore, exerts a greater effect on the 
developing primary dentition compared to an acute episode o f malnutrition.
It could be argued that the children in the groups with liver disease were less ill than 
those with liver grafts. However, many o f the subjects examined in the liver disease 
control groups had been either referred or scheduled for liver transplantation 
themselves. The shortage o f donated liver grafts means that there are many children 
who are severely ill still awaiting transplantation.
5 .4 .5 Delaved eruption and the age o f the child at liver transplantation
The liver transplant recipients with delayed eruption were found to have been 
transplanted at a younger age compared to those who did not have delayed eruption, 
irrespective o f nutritional status. Those with delayed eruption were transplanted at 
mean ages o f 6 months and 12 months respectively compared to 16 and 14 months in 
the non-transplanted controls. The only reasonable explanation for this finding is that 
the delayed eruption might be related to factors directly related to the transplantation 
process itself.
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5.4.6 Delayed eruption and cyclosporin therapy
The common factor in all the subjects with liver grafts was the cyclosporin medication. 
There was an association between mean circulating trough cyclosporin level and the 
number o f teeth present in the children with liver grafts. Therefore, a possible 
alternative explanation to the high prevalence o f delayed eruption in paediatric liver 
transplant recipients is that cyclosporin has a direct effect on the overlying soft tissues 
to prevent the emergence o f the primary dentition.
The possible link between malnutrition in subjects with liver disease and the relation to 
delayed eruption in the primary dentition has already been discussed. However, the 
reason why ‘catch up’ in primary tooth eruption was not evident in this study could be 
due to the effect o f cyclosporin on the mucosa overlying teeth that were already 
delayed in their eruption. In other words, cyclosporin might not have had a direct 
effect on dental development but magnified an already retarded dental development 
prior to transplantation by making emergence o f the teeth more difficult once these 
teeth had regained their eruptive potential.
In the two previous reports o f delayed eruption o f the primary dentition, in subjects 
medicated with an agent known to cause gingival overgrowth, the subjects were 
known to be ‘small for her age ’ and ‘severely handicapped’ (Reich et al 1981: 
Church & Brandt, 1984). In the light o f the findings in this study, it is possible that 
these were also examples o f drug induced thickening o f  the overlying mucosa causing
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delayed eruption in subjects with an existing predisposition to retarded dental 
development.
5.4.7 Delaved eruption and the duration o f cyclosporin therapy
The children with delayed eruption had been transplanted for a longer period o f time 
than those who did not.
An evaluation o f the association between the length o f time a subject had been 
transplanted and the number o f erupted teeth present would have been valuable. 
However, this would only have been possible if all the subjects were exactly the same 
age since there will always be a positive correlation between age and the number o f 
erupted teeth. Nevertheless, in this study, the association between the presence o f 
delayed eruption and the length o f time post transplant is striking and must merit 
further consideration.
5.4.8 The effect o f previous steroid and nifedipine therapy
I f  steroid therapy had any effect o f the eruption on the primary teeth in this study this 
would have been expected to be most apparent soon after receipt o f  a liver graft. 
Blodgett et al (1956) in a study o f the effects o f prolonged corticosteroid therapy on 
structural growth and skeletal maturation in children, clearly demonstrated that
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although the steroids stopped growth when given in high doses, a reduction in dosage 
was almost immediately followed by an upsurge in the growth rate. The findings in 
this study, therefore, discount short term corticosteroid medication as an aetiological 
factor in delayed eruption o f the primary dentition.
Nifedipine is also known to cause gingival overgrowth but there have been no reports 
o f an association with delayed eruption. Furthermore, other reports have shown that 
the effect o f nifedipine on the gingival tissues is reversible when drug therapy is 
discontinued. Nishikawa et al (1991) reported a case o f a 61 year old woman who 
underwent spontaneous regression o f the gingival overgrowth two months after her 
medication was changed. Furthermore, Lederman et al (1984) have reported that if 
the administration o f nifedipine is discontinued, oral signs may improve in as little as 
one w eek .
Therefore, if the previous steroid or nifedipine therapies had been contributory factors 
in the aetiology o f delayed eruption o f the primary dentition in this population one 
would, again, have expected to find the highest prevalence in those subjects who had 
been transplanted for the shortest duration. The findings in this study, therefore, do 
not support the hypothesis that steroids or nifedipine were aetiological factors.
5.4.9 Further study
The effect o f cyclosporin on the overlying soft tissues merits further investigation.
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Cyclosporin-induced gingival overgrowth has never been reported before in 
association with unerupted teeth. Further study into the effect o f cyclosporin on the 
overlying mucosa or fibroblasts might prove to be valuable in ascertaining the 
mechanism by which cyclosporin affects the gingival tissues.
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5.5 Cyclosporin-induced gingival overgrowth
[
5.5.1 Prevalence
This study has shown that the prevalence o f cyclosporin-induced gingival overgrowth 
in a cross-section o f paediatric liver transplant recipients is 55%. This is in keeping 
with a similar study o f paediatric heart transplant recipients in which 10 out o f 19 
subjects had clinically significant gingival overgrowth and used similar methodology 
(Lowry et al 1995).
When the prevalence o f gingival overgrowth is reported in relation to the age at which 
the children were examined the prevalence was lowest in the children under 1 year o f 
age (33%), increasing to 69% in children who were over 10 years o f age. The trough 
cyclosporin concentrations throughout the age-banded groups was similar.
The gingival overgrowth in this study was most commonly observed to cover only 
between 1/2 and 1/3 o f the clinical crown and the severity o f gingival overgrowth was 
similar within the different age groups.
The prevalence and severity o f gingival overgrowth was much less than had hitherto 
been expected, based on the previous published studies into gingival overgrowth in
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both adult and child liver graft recipients who all reported 100 % prevalences (Ross et 
al 1989: Svirsky 1989: Seow eta l 1991: Funakoshi et al 1992).
The individual variation in absorption offers an explanation as to why this study differs 
so markedly from these other studies. It is clear that the variation in cyclosporin 
bioavailability is so great in this population that only large sample sizes will give a true 
reflection o f the prevalence and severity o f cyclosporin-induced gingival overgrowth. 
The current study is the largest one ever undertaken, with the most accurate data on 
cyclosporin levels.
5.5.2 Other factors in the aetiology o f cvclosporin-induced gingival overgrowth
The effect o f other factors such as fibroblast population mix, the presence o f plaque, 
and individual immune response should not be discounted. These are also likely to 
contribute to the variation in the prevalence and severity o f gingival overgrowth.
It was unrealistic to measure plaque and gingival inflammation using specific indices in 
this young child sample. Furthermore, in view o f the diversities between paediatric 
liver graft recipients and their relative sparcity in number, clinical studies into the effect 
o f  these other oral health parameters such as plaque indices and probing depths are 
probably best studied in another, more accessible, paediatric transplant population.
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5.5.3 Gingival overgrowth in infants
The lower prevalence o f gingival overgrowth in infants under 1 year o f age is probably 
not associated to their relatively short exposure time to cyclosporin. Cyclosporin- 
induced gingival overgrowth has been shown to occur as early as 2-6 weeks after the 
commencement o f therapy (Daly et al. 1986). Instead, the lower prevalence o f gingival 
overgrowth in this age group can probably be attributed to their decreased 
bioavailability o f cyclosporin (McMaster et al 1994: Whitington et al 1990: 
Whitington et al 1991). The difficulty in maintaining suboptimal therapeutic levels in 
children possibly relates to a lower exposure to cyclosporin in this group.
5.5.4 Effect o f age at OLT on gingival overgrowth
There were two groups o f children in this study who appeared to have the highest 
prevalence o f gingival overgrowth: those who received liver grafts in their second year 
(70%), and those who received liver grafts when they were over twelve years o f age 
(75%).
There are two possible explanations for these findings. In the 12 year and over group, 
the increased prevalence can be attributed to the onset o f puberty. Daly et al (1986) 
also reported a higher prevalence o f gingival overgrowth in this group, irrespective o f 
sex, and attributed this to fibroblast susceptibility to growth hormone.
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The high prevalence o f gingival overgrowth in the children who were transplanted in 
their second year o f life is more difficult to explain. However, like the pubertal group, 
this is also a time o f rapid growth and it is interesting to note that this is the period o f 
time when many o f the primary teeth are erupting and when there is plaque 
accumulation for the first time.
These findings suggest that there is a Tow prevalence window’ o f cyclosporin-induced 
gingival overgrowth for transplantation after the age o f 3 years but before the onset 
o f puberty. This theory might explain why the previous studies into paediatric liver 
transplantation reported disparate results in respect o f the effect o f duration o f 
cyclosporin therapy, since it is possible that the discrepancy lies not in the duration o f 
cyclosporin itself, but on the effect that cyclosporin exerts on the gingival tissues at 
different ages.
Clearly further study is required, not only to confirm these findings but also to 
determine the underlying cause.
5.5.5 The effect o f duration o f cyclosporin therapy
There appears to be an increasing prevalence o f cyclosporin-induced gingival 
overgrowth with increasing duration o f drug therapy. However, the statistical analysis 
in the cross-sectional study showed that there was a weak inverse correlation between 
gingival overgrowth severity and the duration o f  cyclosporin therapy.
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This study also found that there was an inverse relation between the trough 
cyclosporin concentration and the duration o f therapy. Uncorrected cyclosporin dose is 
known to decrease with increased body size (Whitington et al 1990). Therefore, these 
results might only be a reflection o f the falling concentration o f cyclosporin with age, 
especially when the cyclosporin therapy regimen falls behind somatic growth allowing 
the serum concentration to fall below optimal levels.
It is already clear that maintaining an optimal concentration o f cyclosporin is difficult, 
but this is exacerbated in a growing child. Resolution o f gingival overgrowth with 
reduced or discontinued cyclosporin therapy has been reported (Daly 1992). 
Therefore, it might not be unreasonable to conclude that, in some children, the 
reduction in gingival overgrowth severity over time is related to growth out-stripping 
cyclosporin therapeutic levels.
5.5.6 The relation between trough cyclosporin concentration and gingival 
overgrowth
A significant difference in the trough cyclosporin concentration between those who did 
and those who did not have gingival overgrowth was found in those who were 
examined whilst they were aged between 5 - 1 0  years.
It is clear that cyclosporin is associated with gingival overgrowth but there is 
conflicting published information on the relation between the trough concentrations 
and gingival response (Ross et al 1989: Morisaki et al 1990: Funakoshi et al 1992). 
Therefore, the general lack o f correlation between the trough cyclosporin
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concentration and gingival overgrowth in the present study is not altogether 
surprising.
Although the trough cyclosporin concentration is the most commonly used in clinical 
practice, it is now accepted that it is a very poor guide to the therapeutic efficacy o f 
the drug. It has been shown that there is little correlation between cyclosporin dose, 
trough levels, and total exposure to the drug (Lindholm et al 1993).
5.5.7 Neoral
The Neoral microemulsion formulation has been demonstrated to have more consistent 
absorption and a closer correlation between blood trough values and drug exposure 
(AUC) in children (Lin & Lee 1996). Therefore, trough cyclosporin levels might be a 
more meaningful determinant o f individual bioavailability in this new formulation than 
has been found in Sandimmune (Levy 1996).
However, the bioavailability and accuracy o f the trough values o f Neoral compared to 
those o f Sandimmune have already been examined in a study o f heart transplant 
patients in Harefield Hospital. The investigators confirmed that the pharmacokinetic 
profile o f Neoral was indeed more consistent in size and shape and that the Cmax 
concentration was significantly higher than Sandimmune, but they also found that the 
trough levels in both preparations were the same (Mikhail et al 1994). In addition, 
they reported that no significant difference was seen in the correlation between trough
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levels and AUCs in either formulation. They, therefore, concluded that the use of 
trough levels as an indicator o f total exposure to the drug will be no more reliable in 
Neoral than they proved to be with Sandimmune. They also recommended that the 
increased predictability o f absorption o f Neoral should allow further investigation to 
establish whether peak, average or trough levels correlate best with the absence o f 
rejection and toxicity.
5.5.8 The possible effect of Neoral on the gingival tissues
There have been conflicting reports in the medical literature as to whether Neoral has 
the same side effects as the Sandimmune formulation. Numerous studies have reported 
that despite the higher AUC and Cmax o f the Neoral preparation that there is no 
increased toxicity (Levy 1996: Barone et al 1996: Chang & Choc 1996 ].
However, some authors have also warned that the increased exposure to cyclosporin 
might increase drug related adverse effects (Grant et al 1996). Bennett et al ( 1996) 
reported nephrotoxicity, arteriolopathy, microcalcification and fibrin thrombi in the 
glomeruli in renal graft recipients whose medication had been changed to Neoral. They 
suggested that the two cyclosporin preparations were not equivalent in terms o f safety 
or efficacy.
A reduction in dosage o f cyclosporin o f between 6% to 20% has been recommended 
following transition to the Neoral preparation but this has been shown to provide 
insufficient immunosuppression, especially in renal transplant recipients. In this group,
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the Neoral dose needs to very similar to that o f  Sandimmune in order to achieve 
comparable drug exposure and maintain trough values (Levy 1996). The current 
British National Formulary recommends that Neoral is substituted milligramme for 
milligramme.
The findings in this study suggest that there is likely to be an increased prevalence 
and severity o f gingival overgrowth associated with the increased bioavailability of 
cyclosporin. Furthermore, it is clear that, until a valid means o f measuring the 
cyclosporin bioavailability is developed, the true association between cyclosporin 
concentration and gingival overgrowth will continue to elude dental researchers.
5.5.9 The effect o f concomitant nifedipine medication on gingival overgrowth
Although nifedipine is also known to cause gingival overgrowth, this study found no 
association between nifedipine medication and either the presence or the severity o f 
gingival overgrowth. This lack o f association between the presence or degree of 
gingival overgrowth and nifedipine medication either on its own or with cyclosporin is 
possibly a reflection o f the very short length o f  time that nifedipine is prescribed for the 
children with liver grafts. However, it is interesting that Lowry et al (1995) also failed 
to show that concomitant nifedipine therapy had an effect on either the presence or the 
severity o f gingival overgrowth in their study o f paediatric heart transplant recipients.
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5.6 Cytomegalovirus
Forty-seven percent o f the children had gingival overgrowth but for the majority o f 
these, this was only mild.
In this investigation, the circulating cyclosporin level could be considered to be a 
constant variable. There was no relationship found between the circulating cyclosporin 
level and either the presence or the severity o f the gingival overgrowth in the sample 
o f 59 children. Moreover, there was no significant difference between the circulating 
cyclosporin levels o f the 31 children who had no gingival overgrowth compared to the 
28 who did. Furthermore, the cyclosporin levels were similar in the CMV 
seropositive and CMV seronegative groups o f children.
If CMV was in part responsible for gingival overgrowth a significant difference in the 
prevalence o f gingival overgrowth between those who were CMV seropositive and 
those who were not would be expected. This study found no such evidence. 
Moreover, the gingival overgrowth was not found to be more severe in those who 
were CMV seropositive.
Moreover, since there is an increased risk o f CMV disease following primary infection 
(Davison et al 1993) it is not unreasonable to assume that those patients who had 
primary CMV infection following transplantation would be more susceptible to the 
effect o f cyclosporin on the gingival tissues, if CMV was a contributory factor.
However, this investigation also failed to show either an increased prevalence or an 
increased severity o f gingival overgrowth in subjects with primary infection.
Therefore, although Epstein et al (1992) suggested that CMV might exert an influence 
on cyclosporin-induced gingival overgrowth this was not confirmed by this 
investigation.
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5.7 Further study in liver graft recipients
5 .7.1 The demand for dental care
The increased survival rate o f paediatric liver graft recipients will doubtless lead to a 
future dental demand for correction o f discoloured and hypoplastic teeth and gingival 
overgrowth. In addition, parents o f these children require preventive advice and 
therapy and dental counselling in respect o f the need for aesthetic treatment in later 
years. This must place a higher demand on the dental profession but the type o f service 
provision, demand and cost o f providing the specialist care will need to be assessed.
5.7.2 Monitoring o f the effect o f Neoral on gingival overgrowth in children
Further study will be required to clarify the effect o f the microemulsion preparation o f 
cyclosporin on the gingiva. This will be particularly relevant in the light o f the increase 
in liver transplantation in babies under one year, since Neoral is especially targeted for 
use in this group. If  the prevalence and severity o f gingival overgrowth is indeed 
strongly related to bioavailability, this group o f children in particular are likely to 
encounter more severe problems in relation to delayed eruption, prolonged teething 
and poor nutrition related to difficulties in mastication.
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5.7.3 Clarification o f the need for antibiotic prophylaxis
The published guidelines on the oral care o f patients who have received liver grafts 
recommend steroid cover and prophylactic antibiotic therapy in accordance with 
American Heart Association guidelines for invasive procedures. These guidelines 
appear to be based on the experience o f treating patients with bone marrow and renal 
transplants rather than those who have received liver grafts. No serious consequence 
o f bacteraemia caused by oral flora to any solid tissue grafts has ever been reported. 
Greenberg and Cohen (1977) in a study o f the oral and systemic complications in 
twenty-seven renal transplant recipients, reported no deaths due to infection.
| Therefore, even the provision of antibiotic prophylaxis, although sensible, has still to
|
j be evaluated. Moreover, the majority o f paediatric liver transplant recipients only
i
receive steroid therapy during the first three months post transplantation. The steroid
i
i
therapy is discontinued to alleviate the risk o f infection. Therefore, the need to provide
I
! steroid cover is also still to be clarified.
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Chapter Six
Conclusion
213
6.1 Combined conclusion of the five investigations
This is the largest investigation into the oral effects o f paediatric liver transplantation
that has ever been conducted. The results have shown that paediatric liver graft
recipients have a high prevalence o f intrinsic green pigmentation (45%), delayed
eruption o f the primary dentition (40%), and cyclosporin-induced gingival overgrowth
; (55%). However, the prevalence o f enamel hypoplasia was only 11% and this was
I lower than had hitherto been expected, based on the reports o f previous investigators.
|j
|
In this study, no association was found between the trough cyclosporin concentration 
| and either the presence or the severity o f gingival overgrowth in paediatric liver graft 
[ recipients. This finding was attributed to both the questionable reliability o f the trough
i
[
| cyclosporin concentration and to variation in cyclosporin bioavailability in this 
population. The results also failed to show that concomitant nifedipine therapy 
adversely affected cyclosporin-induced gingival overgrowth. The most likely 
explanation for this result is that children with liver grafts are often only medicated 
with the drug for a short period o f time.
!
|
i
|
i
1 This study confirmed that, not only was there wide inter and intra-individual variation
I in the severity o f the intrinsic green pigmentation in the primary dentition, but
|
| primary molar teeth were also found to be more severely pigmented than the primary
i
j  incisors. There was also wide variation in the severity o f the green pigmentation in 
permanent teeth but there was less intra-individual variation. The clinical findings
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suggested that the deposition of the pigment could be incremental in nature and 
occurred post-natally.
Contrary to earlier reports, no improvement in the severity o f the intrinsic green 
pigmentation in primary teeth was observed. The previous studies used subjective 
rather than objective measurements of the severity o f the pigmentation. Nevertheless, 
this study highlighted the difficulties in evaluating the severity and extent o f  intrinsic 
pigmentation, particularly in primary incisors.
ii
! Malnutrition alone was not found to be a significant factor in the aetiology o f delayed
I
eruption o f the primary dentition. However, there was evidence that malnutrition due
i
| to liver disease contributes to the high prevalence o f delayed eruption in those children 
who later receive a liver graft. The results o f this study also strongly suggest that 
cyclosporin therapy is a significant aetiological factor. It is proposed that cyclosporin 
causes thickening o f the overlying mucosa and thereby inhibits the emergence o f a
[
| previously delayed primary tooth.
The prevalence o f gingival overgrowth was found to vary with the age o f  the child. 
The prevalence was lower in babies but higher in adolescents and around the time that 
the primary dentition is erupting. The results o f this study also showed that the 
prevalence o f cyclosporin-induced gingival overgrowth varied according to the age at 
which a child received a liver graft. Although the prevalence o f gingival overgrowth
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was found to increase with the duration o f the cyclosporin therapy, no significant 
statistical association was found. These findings could be attributed to the poorer 
bioavailability o f cyclosporin in infants and the adverse effect o f puberty in 
adolescents. Nevertheless, the results in this investigation also provide the most likely 
explanation for the disparate reports o f gingival overgrowth prevalence in previous 
studies, since many o f them included samples that mixed children and adolescents with 
adults.
This study showed that cytomegalovirus did not influence cyclosporin-induced gingival 
overgrowth.
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6.2 The null hypotheses
On the basis o f the results in this study only two o f the null hypotheses could be 
entirely rejected:
1. Children with liver grafts did have a high prevalence o f intrinsic green 
pigmentation, delayed eruption o f the primary dentition and cyclosporin-induced 
gingival overgrowth but they did not have a high prevalence o f enamel hypoplasia. 
Null hypothesis not entirely rejected.
2. The clinical findings suggest that the intrinsic green pigmentation was deposited 
incrementally post natally. There was no improvement in the severity o f the green 
pigmentation with time.
Null hypothesis rejected
3. Delayed eruption o f the primary dentition was found to be related to the previous 
liver disease, malnutrition and cyclosporin therapy.
Null hypothesis rejected.
4. There was no association between the trough cyclosporin concentration and 
gingival overgrowth in paediatric liver graft recipients.
Null hypothesis accepted.
5. Prevalence o f cyclosporin-induced gingival overgrowth was affected by the age o f 
the child, their age at transplantation, the duration o f cyclosporin therapy. 
Null hypothesis rejected.
6. Cytomegalovirus does not influence the effect o f cyclosporin on the gingival tissues. 
Null hypothesis accepted.
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Oral findings in children with liver transplants
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Summary A report is presented of a prospective study into the oral manifestations of li ver 
disease in children. Fifty-five children who had received a liver transplant were examined; 
their ages ranged from 8 months to 16 years 2 months, and 37 of them were under 5 years 
of age. The following information was noted: the teeth that were erupted, the presence and 
severity of enamel hypoplasia and of gingival hyperplasia, and the presence of intrinsic 
discoloration. Results showed that seven of the 17 children under 3 years of age had 
delayed eruption of teeth. Six children had enamel hypoplasia, three in permanent incisors 
and three in primary incisors. Intrinsic discoloration was found in the primary dentition 
of 25 children (23 of whom had biliary atresia prior to receiving the transplant) and in one 
child’s permanent incisors. Thirty-four children had gingival hyperplasia. There,was a 
significant inverse relationship between the length of time since transplantation and the 
severity of gingival hyperplasia. Analysis of variance failed to show any association 
between serum cyclosporin levels and the severity of gingival hyperplasia. There was no 
significant relationship between current nifedipine medication and the presence of gingival 
hyperplasia.
Introduction
Liver transplantation is an accepted treatment for 
acute liver failure, chronic liver failure, metabolic 
liver disease and malignancy. Indeed, the only 
contraindications to liver transplantation are severe 
cardiopulmonary disease and irreversible organic 
brain disease [1]. Liver grafts are matched by ABO  
blood group, liver size and, when possible, by 
cytomegalovirus status. Orthotopic liver transplan­
tation is a technique in which the recipient's liver is 
removed and a donor’s liver is implanted in the 
original site [2]. To overcome the shortage o f child 
donors, reduction hepatectomies have recently been 
developed. This is a procedure in which part o f an 
adult liver is cut down to fit a child. Reduction 
hepatectomies now make up 4 6 - 5 0 #  of the total 
grafts in children and have enabled babies under 1 
year o f age and 10 kg in weight to be offered liver 
transplantation for the first time f3 ,4 1.
Since 1967 more than a thousand liver transplanta-
C orresp on d en ee: D r M . T . H o sey , T h e  D en ia l H o sp ita l. St C h a d 's  
Q u ee n sw a y . B irm in gham  B 4  6 N N , E n glan d .
tions have been carried out in North America and 
Europe. This increase in numbers is due to earlier 
diagnosis and referral, improved patient selection and 
operative techniques, and to the successful develop­
ment o f immunosuppressive agents such as Cyclo­
sporin A and FK506. [1,5,6]. Indeed, 1- and 2-year 
actuarial survival rates following transplantation in 
world centres are now in excess o f 85% [11.
Children with liver disease require careful dental 
management due to their inadequate drug and protein 
metabolism and tendency towards prolonged bleed­
ing. Intrinsic tooth discoloration, particularly in 
relation to biliary atresia, has also been reported (7,8], 
However, as liver transplantation becom es increas­
ingly common, problems associated with dental 
management will also becom e more prevalent. So far, 
published studies have not included pre-school chil­
dren and sample sizes have been small. Furthermore, 
research has largely been confined to the effects o f 
Cyclosporin A medication on the gingival tissues 
[5,9]; other possible oral manifestations associated 
with liver transplantation have not been investigated.
The aim of this paper is to report on delayed 
eruption o f teeth, intrinsic staining, enamel hypo-
BSPD ;iikI lAl’D. InternalH mul J o u rn a l at I’uciliitrin 5 I 29
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plasm and gingival hyperplasia in a group of children 
who had received orthotopic lo c i transplants.
Methods
The Liver Unit in The Children's Hospital, Birming­
ham, serves the West Midlands Region, the largest in 
the UK. with a catchment population o f over five 
million. It is a supra-regional centre and as such 
accepts referrals from all over the UK. The Dental 
Department works closely with the Liver Unit team 
and is involved with the patients as soon as they 
present for medical assessment prior to placement on 
the liver transplant waiting list.
Fifty-five children (32 girls and 23 boys) were 
examined over an 18-month period. Their mean age 
was 4 years 8 months (range 8 months to 16 years 2 
months, median 3 years 6 months) The children were 
examined in the hospital’s dental unit by one o f the 
authors (M.T.H.) when they attended the Liver Unit 
for review. Other children who had recently received 
transplants and who were still in-patients were also 
included. The following details o f medical and 
transplant history were noted: age and sex o f the 
patient; age at transplantation: diagnosis prior to 
transplantation; length o f time since transplantation; 
drug history, particularly cyclosporin, nifedipine and 
steroid therapy (generally, all patients are prescribed 
both nifedipine and prednisolone for the first 3 months 
after transplantation only); and mean serum cyclo­
sporin level, calculated from data obtained from blood 
samples taken on the day of examination and on the 
previous two visits.
The- following information was recorded at the 
dental examination:
Teeth p resen t. All erupted or partially erupted teeth 
were charted as present. A tooth was considered to be 
delayed in its eruption when there was a delay of more 
than 6 months beyond the normal eruption age, based 
on the data presented by Proflii | 10) (Table 1).
T a b le  I. ’Normal" a c e s ( I I I O I I l l l S ) lor erupiio:
p rim ary teeth  (a cco r d in g to Proflii i m p
M; ix diary Vlandihul;
C entral in c iso r Id S
Lateral in c iso r 1 1 13
C an in e Id 3d
hirst m olar Id Id
S eco n d  m olar > *7
T a b le  2 C n ier ia  tor sco r in g  en a m el h yp op lasia  
i I’liy Istrnp iV le j e r s k o v  [ 1 1 1).
C l i n i c a l  f i n d i n g  S c o r e
N arrow  w h ite  lin es  
P ron ou n ced  w h ite  lin e s  
C lo u d y  areas  
Kntire su it ace op a q u e  
O p acity  and pits  
H orizon tal h and s o f  p its  
O uter en a m el lost <  h a lf  su rface  
O u ter en a m el lost >  h a lf  su r face  
C h a n g es  in a n a tom y
H ypop lastic  defec ts. The Thylstrup & Fejerskov 
Index ( i l |  was used. The criteria are outlined in 
Table 2.
In trinsic sta in ing  o f  the teeth. In these patients 
the intrinsic stain is green in colour and although 
not readily matched to current shade guides it is 
readily distinguishable as ‘green’. Although a 
colour scale of the severity o f the ‘greenness’ was 
developed and used to score each tooth it became 
clear that when intrinsic staining did occur in the 
primary dentition all the primary dentition was 
affected to som e degree and so, for the purposes o f  this 
study, intrinsic green staining was scored as being 
present or absent.
G in g iva l h yperp la sia . Recently published methods 
of measuring gingival hyperplasia [12] necessitate 
taking impressions and making study casts, but 
this was found to be unacceptable to the very 
young children in our sample. Therefore a simplified 
method was used: the diagnostic criteria are shown in 
Table 3.
T a b le  3. C riteria toi sco r in g  g in g iv a l h yp erp lasia .
C lin ica l finding S co re
N o  h yperp lasia 0
H yp erp lasia  ex ten d in g  to  1/3 o f  the cro w n 1
H yp erp lasia  ex ten d in g  to m id d le  o f  cro w n i
H yp erp lasia  ex ten d in g  o v e r  3 /3  o f  the cr o w n 3
H yp erp lasia  c o m p le te ly  c o v e r in g  the cr o w n 4
Siatisiii a l  analysis
Data were analysed using the SPSSPC statistics 
package The association between the level o f
(i;: lisl’l I .-iii! |\l*1> In i,n ii itm im l .ln u n u tl o f r u t 'd u u n f  /Vh/iOm 5 I
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gingival hyperplasia and circulating cyclosporin 
levels was examined using analysis of variance. 
The association between the presence of gingival 
hyperplasia and concurrent nifedipine medication 
was examined using the chi-squared test. Pearson’s 
Product Moment Correlation Coefficient was used to 
quantify the association between the length of time 
since transplantation and the severity of gingival 
hyperplasia.
Results
The mean length of time between transplantation and 
examination was 1 year 5 months (range 1 month to 
5 years). The mean age at transplantation was 3 years 
4 months (range 6 months to 14 years 6 months). The 
findings related to delayed eruption, enamel hypo­
plasia. intrinsic staining and gingival hyperplasia are 
shown in Table 4.
T ab le  4. Dental findings in 55 children with liver
transplants.
N o . o f  children
Exam ined A ffected
D elayed eruption
Primary teeth 42 7
Permanent teeth 13 0
Enamel hypoplasia
Primary incisors 42 3
Permanent incisors 13 3
Intrinsic staining
Primary teeth 42 25
Permanent teeth 13 1*
Ciingival hyperplasia 55 34
‘ Early m ixed dentition.
Delaved eruption
There were 17 children under 3 years of age. Eruption 
nf various primary teeth was delayed in seven (41%) 
pf these infants (i.e. delay of more than 6 months 
beyond normal' eruption age 11()|). For example, one 
child aged 22 months had no erupted primary teeth 
.uni three had only primary central incisors erupted at 
]() months of age. All seven of these children had 
suffered from biliary atresia and six of them had been 
medically diagnosed as having ‘failed to thrive’. No 
delay ed eruption was found in children above 3 years 
>f age.
'»*' usi’0 .Iiui 1 A I’D. IntcriiiiiiiHuil .ti'iirnnl <’t / ‘.irtlin lrn  /Vwn.v/rv 5: I
Enamel hypoplasia
Three children had evidence of enamel hypoplasia in 
permanent central incisors (two score ‘ 1’ and one 
score ‘2’); the hypoplastic areas corresponded to the 
stage of development of these teeth at the time of 
transplantation. Three other children had hypoplastic 
defects (score ‘ D i n  primary central incisors. Enamel 
hypoplasia was not found in any other teeth, but it 
should be noted that the children were still in the 
primary dentition stage or had only just erupted their 
mandibular and maxillary permanent incisors.
Intrinsic staining
Twenty-five children had intrinsic green staining of 
the primary dentition; 23 of these had previously been 
diagnosed as having biliary atresia. All the primary 
teeth of the 25 children were affected but the primary 
first and second molars were more deeply stained than 
the incisors and canines. One patient had intrinsic 
staining affecting permanent incisors; she had re­
ceived a transplant relatively late compared to the 
others who had biliary atresia and had therefore 
remained jaundiced for much of her infancy.
Gingival hyperplasia
Thirty-four of the 55 children had gingival hyper­
plasia (11 score ‘ 1’, 17 score ‘2’ and six scored ‘3 ’) 
There was a significant inverse correlation between 
the length of time since transplantation and the 
severity of gingival hyperplasia (Pearson's Corre­
lation Coefficient r = -0 -3 3 ,  P < 0  01)
Serum cyclosporin levels ranged from 0 to 342 ng/ 
ml. mean 152 ng/ml; there was no significant relation­
ship between the circulating cyclosporin level and the 
severity of gingival hyperplasia (analysis of variance, 
F =  0-69. P = 0-78).
Fourteen patients were taking nifedipine in addition 
to cyclosporin at the time of the dental examination. 
The mean time they had been taking nifedipine was 
4 months (range 1-12 months). There was no 
significant relationship between the presence of 
gingival hyperplasia and concomitant nifedipine 
medication (chi-squared =  ()• 17. P = 0-77).
Discussion
Delayed eruption ot teeth was noted in seven of the 17 
children under 3 years of age. Previous research
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indicating that protein calorie malnutrition leads to a 
delay in primary tooth eruption [13] offers an 
explanation as to why delayed eruption was found to 
be more prevalent in children who had suffered from 
biliary atresia, since these children are frequently 
undernourished. However, the association between 
nutritional status and delayed eruption in liver 
transplant patients requires more detailed research. 
Another factor that may be relevant is Cyclosporin 
A-induced fibroblast stimulation within the gingival 
mucosa, but this has not been investigated.
Palliative treatments such as the use of teething 
rings, hard and fibrous foods on which to gnaw, 
teething gels and systemic analgesia were recom­
mended to the parents. Forewarning parents, es­
pecially of children with biliary atresia, of the 
likelihood of delayed eruption helped to allay parental 
anxiety.
The position of the enamel hypoplastic lesions in 
the affected permanent incisors of three children 
corresponded to the stage of dental development at the 
time of transplantation. The intrinsic green staining 
that affected die erupted permanent teeth of one of the 
children also corresponded to the timing of severe 
metabolic disturbance but, since all surfaces of the 
affected teeth were stained, this was probably due to 
the original liver disease, which was biliary atresia. 
Therefore, further long-term follow-up is required to 
examine the association between liver transplan­
tation, enamel hypoplasia and intrinsic staining.
It is known that Cyclosporin A is associated with 
gingival hyperplasia, but there is conflicting published 
information on dose response [5,9,14], and so the lack 
of correlation between circulating Cyclosporin A 
levels and gingival hyperplasia in the current study is 
hot altogether surprising.
Nifedipine is also known to cause gingival hyper­
plasia. Patients often receive nifedipine for the first 
few months following their liver transplantation to 
offset the hypertensive effect of Cyclosporin A. 
Indeed, Seymour [15] reported that 51% of renal 
transplant patients treated with Cyclosporin A and 
nifedipine developed gingival overgrowth. The lack 
of association between the presence or degree of 
gingival hyperplasia and nifedipine medication either 
on its own or with Cyclosporin A is possibly a 
reflection of the very short length of time that 
nifedipine was prescribed for these children with liver 
transplants.
The significant inverse correlation between the 
severity of gingival hyperplasia and length of time
after transplantation could be due to the gradual 
decrease in Cyclosporin A dose, but this is not 
supported by the results of our study. Other authors 
have suggested that patients build up a resistance to 
stimulation of gingival fibroblasts or that the degree 
of gingival hyperplasia depends upon the sensitivity 
of the individual [5,15], but no study has yet been 
undertaken to examine this more carefully. However, 
our study has demonstrated that the effect of Cy­
closporin A on the gingivae may involve other factors.
Prior to liver transplantation it is important to carry 
out a full dental, examination and to treat potential 
sources of infection aggressively. High-speed suction 
during operative dental procedures to guard against 
ingestion of blood has also been advocated, because 
blood is metabolized by the liver [2,6]. Preventive 
care and careful parental counselling is of great 
importance if good oral health is to be maintained. In 
our experience, this is best achieved when liver 
transplantation is first contemplated, because dental 
care is then seen by the family as being an integral part 
of the child’s treatment. Children who already 
attended their local dentist regularly were advised to 
continue.
Following liver transplantation, patients should be 
examined regularly and receive topical fluoride 
application and reinforcement of preventive advice. It 
is also useful to liaise with their dietitian, because 
many are on high carbohydrate supplementation. 
Some authors [6] have recommended prophylactic 
antibiotic therapy in accordance with American Heart 
Association guidelines in which the standard prophy­
laxis for low-risk patients is Penicillin V. However, no 
serious consequence of bacteraemia caused by oral 
flora to solid tissue grafts has been reported. Therefore 
it would seem more appropriate to treat these patients 
the same as any other with immunosuppression, and 
prescribe antibiotics only when required. Stringent 
preventive therapy to avoid dental sepsis altogether, 
and rigorous treatment prior to transplantation, are the 
most effective measures. Intermittent steroid therapy 
is discontinued by 3 months after liver transplantation 
and therefore steroid cover is generally not indicated 
for dental procedures.
Recipients of liver transplants are becoming ever 
younger and more numerous, and dentists will 
increasingly be called upon to manage these patients. 
Therefore it is important that they should be aware of 
problems which might arise, such as delayed eruption 
of primary teeth, and of the need for stringent 
preventive care and advice both before and after
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transplantation. Dentists can play a vital role not only 
in co-operating in the general medical management 
but also in helping these children and their parents 
adjust to normal life following recovery.
Manifestations orales chez des enfants hepato- 
transplantes
Resume. Une etude prospective des manifestations 
orales chez des enfants soufffant de maladie hepadque 
a ete entreprise chez cinquante cinq enfants ay ant re?u 
un transplant hdpatique. Leur age s’dtalait de 8 mois 
&16 ans 2 mois et 37 d’entre eux avaient moins de trois 
ans. Les informations suivantes ont 6t6 notees: les 
dents ayant fait leur eruption, la presence et la severite 
des hypoplasies, des hyperplasies gingivales, des 
decolorations intrinseques. Les resultats ont montre 
que 7 des 17 enfants ages de moins de 3 ans avaient 
des retards d’eruption. Six enfants avaient des 
hypoplasies de l’6mail, trois sur les incisives perma- 
nentes et trois sur les incisives temporaires. Des 
decolorations intrinseques ont ete retrouvees dans la 
dentition temporaire de 25 enfants (23 d’entre-eux 
avaient eu une atrdsie biliaire avant la transplan­
tation), et sur les incisives permanentes d’un enfant. 
Trente enfants avaient une hyperplasie gingivale. II y 
avait une relation significative inversde entre l’anci- 
ennetd de la transplantation hdpatique et la sdveritd 
de Thyperplasie. L’analyse de variance n’a montrd 
d’association entre le taux de cyclosporine dans le 
sang et la sdveritd de Thyperplasie gingivale. D n’y 
avait pas de relation significative entre le traitement 
par nifedipine et la presence d’hyperplasie gingivale.
Orale Manifestationen bei Kindern mit Leber- 
transplantaten
Zusammenfassung. 55 Kinder, nach Lebertrans- 
plantationen wurden untersucht. Das Alter bewegte 
sich zwischen 8 Monaten bis 16 Jahre und 2 Monate. 
37 davon waren weniger als 3 Jahre alt. Die folgenden 
Befunde wurden registriert: der Stand des Zahndurch- 
bruches, das Vorhandensein und der Schweregrad von 
Schmelzhypoplasien, eventuele Verfarbungen und 
Gingivahyperplaisen. Man fand dass 7 der 37 Kinder 
unter 3 Jahren einen verzogerten Zahndurchbruch 
aufwiesen, ebenso hatten sie Hypoplasien, bei 3 
Kindern in den bleibenden Frontzahnen und bei 3 in 
den Milchfrontzahnen. Verfarbungen wurden an den 
Milchzahnen von 25 Kindern und bei einem Kind 
an den bleibenden Frontzahnen gefunden. Von den
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Kindern mit betroffenen Milchzahnen litten 23 vor 
der Transplantation an einer Gallenatresie. Bel 30 
Kindern wurde eine Gingivahyperplasie diagnos- 
tiziert. Eine signifikante umgekehrten Relation, 
wurde festgestellt, zwischen der Zeitspanne seit der 
Transplantation und dem Schweregrad der Gingiva- 
len Hyperplasie. In einer weiteren Analyse fand man 
keine Beziehung zwischen dem Zyklosporinspiegel 
im Serum und dem Schweregrad der Gingivahyper­
plasie. Es war keine signifikante Beziehung zwischen 
der laufenden Nifedipine Medikation und der Gingi­
vahyperplasie festzustellen.
Manifestaciones orales en ninos con transplantes 
del higado
Resumen. Se presenta un reporte de un estudio 
prospectivo sobre las manifestaciones orales en ninos 
que han recibido transplantes del hfgado. Se examind 
un total de 55 ninos (de 8 meses a 16 anos y 2 meses 
de edad; 37 de elos menores de 3 anos de edad) que 
habfan recibido transplante del hfgado. La siguiente 
information fue anotado: dientes erupcionados, pres- 
entia y severidad de hipoplasia del esmalte y de 
hiperplasia gingival, y la presencia de pigmentaciones 
intrfnsecas. Los resultados mostraron que 7 de los 17 
ninos menores de 3 anos de edad presentaron erupcidn 
dental retardada. Seis de los ninos presentaron 
hipoplasia del esmalte, tres en los incisivos permanen­
tes y tres en los incisivos temporales. Pigmentaciones 
intrfnsecas fiieron observadas en la dentition tempo­
ral de 25 ninos y en los incisivos permanentes de un 
nifio (23 de ellos tenfan atresia billar antes de recibir 
el implante). Treinta ninos presenraron hiperplasia 
gingival. No hubo relation inversamente propor­
tional entre el tiempo transcurrido despues del 
transplante y la severidad de la hiperplasia gingival. 
El an&lisis de varianza no mostro asociacion entre los 
niveles de ciclosporina serica y la severidad de la 
hiperplasia gingival. No hubo relation significativa 
entre la medication con nifedipina y la presencia de 
hiperplasia gingival.
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